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vii
Abstract

A PRE AND POST EXERCISE COMPARISON OF THREE ASSESSMENT TOOLS
COMMONLY EMPLYED TO ASSESS VASCULAR FUNCTION
By: Lorena Salom, BS.
A thesis submitted in partial fulfillment of the requirements for the degree of Masters in
Science at Virginia Commonwealth University
Virginia Commonwealth University

Major Director: Dr. Ronald K. Evans
Department of Health and Human Performance

Clinical research efforts have recently focused on the detection of subclinical
indicators and precursors of cardiovascular disease (CDV), including endothelial
dysfunction (ED). Several vascular assessment tools have been developed as a means of
detecting early alterations in vascular responses and subsequent characterization of ED.
However, three of the most commonly employed techniques have several methodological
differences, including the fact that each technique evaluates a different component of the
vasculature. Flow mediated dilation (FMD) via ultrasound evaluates vascular function of
the large conduit vessels such as the brachial artery. Strain gauge plethysmography
(SGP) measures vasodilatory capacity of resistance vessels by assessing forearm blood
flow. Lastly, Peripheral artery tonometry (PAT) evaluates the ratio of pulse wave
amplitude (PWA) by assessing the microcirculation of the fingers. While these measures
are typically performed during a resting condition, there has been recent interest in
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vii
evaluating vascular responses following an acute bout of exercise. The documents
contained herein include a review of the relevant literature related to mechanisms of
vessel function, assessment of vascular dysfunction using non-invasive tools, and
vascular responses brought on by different types and intensities of exercise. Additionally,
a manuscript is included which details a pilot research study designed to compare the preand post-exercise reactive hyperemia responses to 5 minutes of occlusion as evaluated by
SGP, FMD and PAT in apparently healthy, untrained males. Relationships among the
primary outcome variables obtained from the three techniques both before and after
exercise are also evaluated. It is our hope that this initial pilot study in apparently healthy
subjects will provide a foundation on which to develop a vascular function assessment
protocol that will improve early detection of ED and therefore earlier intervention and
ultimate reduction of CVD mortality.

9

I. INTRODUCTION

Cardiovascular Disease (CVD) continues to be the leading cause of death
worldwide (He & MacGregor, 2009). Recently, researchers have shifted their attention
to recognizing the preliminary signs of CVD, in hopes of preventing and reversing the
early development of vascular abnormalities. Subclinical indications of CVD include
vessel wall abnormalities and delayed vascular responses. Vascular reactivity refers to the
morphological and physiological changes that blood vessels undergo in response to a
stimulus. This self-regulation of tone and adjustment to changes in blood flow are
endothelium-dependent, and imperative to normal vascular function. Impaired
endothelium-dependent vasodilation is the main manifestation of poor vascular reactivity,
and could predict the risk of cardiovascular incidents (Schächinger, Britten & Zeiher,
2000). In fact, endothelial dysfunction (ED) has been shown to be a stronger predictor of
cardiovascular disease than classic risk factors for coronary artery disease such as
hypertension, hypercholesterolemia, smoking, family history, and evidence of
atherosclerosis incidents (Schächinger, Britten & Zeiher, 2000). ED is defined as the
progressive development of irregular vascular function, such as abnormal vessel tone,
loss of the endothelium’s atheroprotective properties, and most notably, diminished nitric
oxide (NO) availability (Vane, Anggård & Botting, 1990, Quyyumi, 1995). Fortunately,
ED is considered to be a treatable stage of CVD development.
Cardiovascular disease treatments range from medicinal regimens to high risk
invasive surgical procedures. Angiotensin-converting enzyme (ACE) inhibitors,
angiotensin receptor blockers (ARBs) and beta-adrenergic antagonists are commonly
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used drug therapies for hypertension, coronary artery disease and other vascular
complications (Gustafsson, Segura & Ruilope, 2010). Although mostly effective at
preventing cardiovascular events, some patients on such therapies will still develop heart
failure regardless of the type of drug therapy (Verdecchia, et al., 2009). Invasive
procedures also known as percutaneous coronary interventions (PCIs) include
angioplasty and stenting (Hashemi, et al., 2010). PCIs are common and effective
procedures in the treatment of various cardiovascular diseases, yet these invasive
procedures are risky and recovery can be an arduous process (Hashemi, et al., 2010). The
ineffectiveness and risk associated with cardiovascular disease treatment accentuates the
importance of early detection of ED, thereby preventing the full development of
cardiovascular disease.
Three commonly employed clinical and research tools to evaluate vascular function and
detect ED include brachial artery flow-mediated dilation (FMD) via ultrasound, venous
occlusion strain-gauge plethysmography (SGP), and peripheral artery tonometry (PAT).
All three techniques utilize a pressure cuff that is inflated to suprasystolic pressure
(240mm Hg) for five minutes, substantially minimizing blood flow to the limb.
Following the rapid release of the cuff, oxygenated blood rushes into the hypoxic area
inducing rapid vasodilation in a process known as reactive hyperemia. The extent of the
vessel’s reaction to this process, as well as the time frame in which it occurs, are markers
of vasomotor function (Corretti, et al., 2002 & Dhindsa et al., 2008). While all three
tools have shown a strong ability to evaluate specific parameters related to vascular
health, they do so by evaluating different components of the cardiovascular system. By
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combining their different diagnostic abilities, early CVD detection and prevention may be
substantially enhanced.
Brachial artery flow-mediated dilation (FMD) evaluates vascular function of the
large conduit vessels such as the brachial artery, which allow for increased blood flow to
large areas (Segal & Durling, 1986). FMD utilizes high resolution ultrasound imaging to
scan and measure the diameter of the brachial artery at rest and during hyperemic
conditions. The magnitude and speed of the brachial artery diameter change is indicative
of endothelial function, which is impaired in patients with coronary atherosclerotic
lesions (Zeiher, Schächinger & Minners, 1995). Moreover, recent research has further
pinpointed the location that the FMD technique is evaluating. It was previously believed
that impaired FMD was reflective of abnormal microcirculation, but more recent studies
have found that it directly indicates atherosclerotic processes occurring in the conduit
brachial artery (Padilla et al., 2009). The CVD predictive ability of FMD has been
extensively explored in many healthy and clinical populations, and although confounding
results have been found, there is a general agreement that brachial artery FMD is a useful
tool in the classification of subjects into low, intermediate, or high-risk CVD categories
(Yeboah et al., 2009).
Venous occlusion strain gauge plethysmography (SGP) has been utilized to assess
forearm blood flow as a marker for vascular function. A mercury-filled strain gauge is
wrapped around the thickest portion of the forearm, and it senses the magnitude of
forearm diameter change during a time when venous outflow is occluded, which allows
calculation of arterial inflow at baseline and after an occlusive stress. The reactive
hyperemia induced forearm blood flow (FBF) responses denote vasodilatory capacity of
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resistance vessels, an indicator of vascular health (Patterson, 1955). SGP has proven
effective at detecting ED. (Shechter, Matetzky, Arad, Feinberg & Freimark, 2009).
Peripheral artery tonometry (PAT) is an innovative technique recently developed
to detect ED by determining pulsatile blood volume changes in the fingers. In contrast to
the assessment tools mentioned above, PAT assesses pulsatile capillary blood flow,
which is responsible for blood flow for localized areas such as the fingers and toes
(Hamburg & Benjamin, 2009). Specifically, PAT evaluates the ratio of pulse wave
amplitude (PWA) during reactive hyperemia compared to baseline values to determine
the degree of ED (Heffernan, et al., 2010). The PWA ratio, also referred to as the PAT
Reactive Hyperemic Index (RHI), is becoming an accepted measure of microvascular
ED. Moreover, it has been found to be significantly related to the widely accepted
criterion for ED evaluation, brachial artery FMD (Heffernan, et al., 2010).
The protective effects of exercise on the cardiovascular system in particular have
been the focus of research in the last few decades. The importance of physical activity on
general health has been well recognized and advocated by health organizations such as
the American College of Sports Medicine and the American Heart Association. The
Surgeon General recommends 30 minutes of moderate intensity physical activity on most
days of the week to acquire the beneficial health effects of exercise (www.cdc.gov).
Some of these beneficial effects include but are not limited to improvements in CVD
factors such as high blood pressure, LDL cholesterol, triglycerides and body weight
(Paffenbarger, Jung, Leung & Hyde, 1991). Exercise has also been shown to increase
insulin sensitivity in healthy subjects and decrease insulin resistance in obese and type 2
diabetes patients (Scheen & Paquot, 2001).
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The effects of an acute bout of exercise on vascular function in several different
populations have been evaluated utilizing SGP, PAT and FMD. Using SGP to assess
vasodilatory responses, it was found that FBF was significantly higher following an acute
bout of exercise when compared to resting FBF in both endurance and resistance trained
athletes (Baynard , Miller, & Fernhall, 2003). This same study determined that one bout
of acute maximal exercise increased vasodilatory capacity in both groups. Significant
increases in brachial artery diameter have been detected by FMD via ultrasound
following an acute bout of low intensity exercise, and even greater increases after an
acute bout of high intensity exercise in overweight active and inactive men. (Harris,
Padilla, Hanlon, Rink & Wallace, 2008). Similar findings were observed in studies
investigating the effects of exercise on vascular responses evaluated by PAT (Levin, et
al., 2001). In subjects with coronary artery disease (CAD), altered peripheral vascular
responses were detected during and three minutes following a routine exercise protocol
(Levin, et al., 2001). Altered peripheral vascular responses included abnormal PAT
indices, increased vasoconstriction during the acute exercise bout, as well as less
vasodilation following the exercise.
Although all three techniques have shown to successfully detect exercise induced
vascular changes in different vessel types, all three techniques have not been compared
and contrasted pre and post-acute exercise. Furthermore, some studies have found
diminished vascular function following an acute bout of exercise in diseased populations
(Sylvestro et al.; Mcgowan, et al., 2006). Since the stress applied to the cardiovascular
system by exercise may alter vascular responses to an occlusive stress, assessment of

14

vascular function after a quantitative exercise stress may provide additional predictive
value related to the health of the vasculature.
This document has been organized to include a thorough review of the relevant
literature related to vessel function and assessment of vascular dysfunction using noninvasive tools. Additionally, vascular responses brought on by different types and
intensities of exercise will be presented. The review of literature is followed by a
manuscript titled “A pre and post-exercise comparison of three assessment tools
commonly employed to evaluate vascular function”, which details a pilot research study
designed to compare the pre- and post-exercise reactive hyperemia responses to 5
minutes of occlusion as evaluated by FMD, SGP, and PAT. For each assessment tool,
pre- and post-exercise vascular function responses were evaluated in apparently healthy,
untrained, non-obese males. Additionally, relationships among the primary outcome
variables obtained from the three techniques both before and after exercise were
evaluated.
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II. REVIEW OF RELEVANT LITERATURE
The vascular system is composed of the vessels of the body, including the
arteries and veins and its main purpose is to circulate blood to all body tissues. The
task of providing tissues with sufficient oxygenated blood to meet metabolic demands
is of primary importance, and it emphasizes the need for a comprehensive
understanding of vascular function. Unfavorable changes in endothelial function and
arterial stiffness, hence changes in vascular function, are thought to be predictors of the
development of cardiovascular disease (Wilson, 2005). Detecting these changes may
be beneficial for early detection and prevention of cardiovascular disease, as well as the
determination of the prognosis for future cardiovascular events. Several non-invasive
tools have been developed and are utilized to evaluate vascular function including
brachial artery flow-mediated dilation (FMD) via ultrasound, venous occlusion straingauge plethysmography (SGP), and peripheral artery tonometry (PAT) (Alomari et al.,
2004; Wilson, 2005)
The following is a review of the scientific literature related to vascular
function, molecular mechanisms related to vascular tone, pathogenesis of
atherosclerosis, and the clinical assessment of vascular function utilizing non-invasive
tools. The review is structured to 1) provide background on the function of the
endothelium, 2) provide a detailed description of commonly employed non-invasive
tools for assessing vascular function and their utilization as prognostic indicators of
cardiovascular disease, and 3) provide a review of alterations in vascular function
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brought about by acute and chronic exercise training which may influence vascular
function.
The Endothelium and Vascular Function
The interior surface of all blood vessels is lined by a single layer of endothelial
cells that function as a metabolically active barrier between blood in the vessel lumen
and the blood vessel wall (Terzuoli, Marinello, Frosi, Ciari, & Porcelli, 2008).
Endothelial tissue can also be found in the interior surface of lymphatic vessels and the
heart. An important feature of the endothelium is its ability to detect changes in blood
flow hemodynamics as well as to react to these changes by making appropriate
modifications to return to vascular homeostasis (Simionescu & Antohe, 2006). The
endothelium-dependent response to these changes in hemodynamics includes the
secretion of both vasodilating substances (e.g., nitric oxide (NO) and endotheliumderived hyperpolarizing factor (EDHF)) and vasoconstricting substances (e.g.,
Endothelin 1 and Angiotensin II), which directly affect vascular tone and vascular
reactivity (Verma & Anderson, 2002).
In addition to being an endothelium-derived relaxing factor, NO also contributes
to vessel homeostasis by regulating vascular function. Derived from L-arginine, NO
possesses essential properties that maintain endothelial function and vascular reactivity,
such as hindering platelet aggregation and adherence to blood vessel walls (Ignarro,
1989). In fact, reduced NO bioavailability is a primary contributor to endothelial
dysfunction (Yao et al., 2010). Endothelial dysfunction is considered to be the earliest
clinical indication of risk for cardiovascular diseases, and is closely related to a series
of severe chronic and acute illnesses such as arthrosclerosis, multi-vessel coronary
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artery disease, diabetes mellitus, hypertension, and stroke (Kitta et al., 2009).
Opposing the vasorelaxing effects of NO is an active vasoconstricting peptide,
Angiotensin II (ATII) (Johren, Dendorfer, & Dominiak, 2004). ATII is a potent
vasoconstrictor which works directly on the vascular system through G-protein coupled
receptors, or indirectly by facilitating aldosterone and norepinephrine release (Johren,
Dendorfer, & Dominiak, 2004). An increase in expression of ATII Type 1 receptors
(AT1R) has been strongly linked to atherosclerosis (Libby, 2002). Moreover, it has
been found that over-expression of the ATII Type 2 receptor (AT2R), which opposes
the effects of AT1R, reduces atherosclerotic lesion formation, playing a protective role
against cardiovascular disease (Hu et al., 2008). In addition, studies have found that
ATII regulates the activity of endothelial nitric oxide synthase (eNOS), the enzyme that
catalyzes the formation of NO from L-arginine (Kawashima & Yokoyama, 2004). A
deficit of this important enzyme has been observed in patients with atherosclerosis, as it
reduces NO bioavailability (Kawashima & Yokoyama, 2004). The vascular role of
ATII has been thoroughly investigated, and its activity has been selectively opposed by
AT2R receptor activation, involving the endothelial dependent bradykinin pathway and
NO production (Hannan, Davis, & Widdop, 2003).
Another potential mechanism contributing to the development of endothelial
dysfunction involves the signaling G protein GTPase RhoA and its target Rho kinase
(ROCK), which is directly involved in T-cell transendothelial migration, thrombus
formation, and regulation of the endothelial barrier integrity (Yao et al., 2010).
Detrimental effects on endothelial function are observed with the overactivation of
RhoA/ROCK resulting in reduced eNOS expression, hence a decreased NO
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bioavailability. Furthermore, ROCK inhibitors reverse this effect, upregulating eNOS
expression and NO production (Yao et al., 2010)
Disruption of the activity of vasoactive substances such as NO and ATII can
severely alter vascular balance and may lead to endothelial dysfunction. In addition to
the endothelium, these vasoactive substances also target the smooth muscle cell layer of
the vessel wall, causing vasoconstriction or vasodilation. The role of smooth muscle
cells in vascular function is critical to maintaining vascular health, and their interaction
with vasoactive substances will be further explored below.
Smooth Muscle Cells and their role in Vascular Function
Surrounding the endothelial layer is a thick layer of smooth muscle cells
constituting the media layer of the vessel wall. Vasoconstriction and vasodilation are
mediated by the tonic vascular smooth muscle cells, which behave as multiple,
independent units resulting in graded changes in vascular tone (Fisher, 2010).
Specifically, NO diffuses into the media, and binds to the guanylyl cyclase receptors
starting a cascade of events resulting in an increase in the second messenger cGMP.
Subsequently, this reaction arbitrates vascular processes such as vasorelaxation,
inhibition of platelet activation and migration (Bassil & Ananda-Srivastava, 2007). The
dual effects of vasoactive substances on both the metabolically active endothelium and
on vascular smooth muscle cells compound the significance of their role on vascular
homeostasis and prevention of vessel-related pathogenesis.
Blood vessel types and their mechanisms
There are three major types of blood vessels which differ greatly in size,
function and blood flow control mechanisms. SGP evaluates vascular reactivity of
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resistance vessels, FMD focuses on conduit vessels, and Endo-PAT assesses the
capillaries. Resistance vessels are 50µm or smaller in diameter and are in command of
regional blood flow, whereas conduit vessels such as the brachial artery are much larger
with diameters of several millimeters, allowing for increased blood flow to large areas
(Segal & Durling, 1986). During exercise, blood flow to the muscles is mainly dictated
by resistance vessels, which occurs via a NO-mediated function, as well as cardiac
pump capacity, muscular pump, and the sympathetic system (Saltin B., Radegram G.,
Koskolou M., Roach R., 1998). The significantly smaller capillaries are responsible for
microcirculation, providing blood flow for localized areas such as the fingers and toes.
Digital vascular function at rest and during hyperemic responses has been thoroughly
investigated and directly correlates to vascular function in other regions (Hamburg &
Benjamin, 2009). The differences and similarities in vascular reactivity for each vessel
type following a stressor require further investigation.
Hormonal and Gender effects on Vascular function
Hormones closely linked to the menstrual cycle, such as estrogen and
progesterone, have a direct effect on the endothelium (Lynn, McCord, & Halliwill,
2006). Estrogen receptors are found on the endothelium and estrogen binding elicits
NO release, augmenting a common endothelium relaxing mechanism (Deroo &
Korach, 2006). Elevated estrogen levels in females, and their enhancing effects on
endothelium relaxing mechanisms further denote gender-related differences in vascular
function. These hormonal differences may be advantageous for cardiovascular health in
menstruating females when compared to males. Additional findings state that
endothelial progenitor cells implicated in cardiovascular homeostasis were found to
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oscillate in phase with the menstrual cycle in ovulating women (Fadini et al., 2008). It
is hypothesized that endothelial progenitor cells migrate to the peripheral circulation
during the different phases of the menstrual cycle, and higher levels are found in
ovulating women than in post-menopausal women and males (Fadini et al., 2008).
Future vascular function studies should include females during the various menstrual
cycle phases in order to apply the findings to benefit a larger segment of the population
with the incremental knowledge of endothelial dysfunction detection and treatment.
Additionally, the vasorelaxing effects of estrogen should be further investigated as a
potential hormonal therapy for CVD treatment.
In addition to gonadal steroids, other important hormones alter vascular
mechanisms. Acute augmentations of growth hormone (GH) not only provoke
endothelium dependent vasodilation marked by increased NO synthesis, but also
increased sensitivity to vasodilating agents (Napoli et al., 2003). This study also
suggests the potential therapeutic role of GH on vascular pathogenesis.
Assessment of Vascular function
Assessment of endothelial dysfunction has become increasingly important as the
prevalence of CVD has dramatically risen in the last several decades. There are several
non-invasive assessment tools available to evaluate vascular function. Three of the
most commonly utilized assessment tools are flow mediated dilation (FMD), strain
gauge plethysmography (SGP), and peripheral artery tonometry (PAT). All three
measurement techniques attempt to occlude all blood flow to the limb with a pressure
cuff inflated to supra systolic pressures, creating a hypoxic state. Reactive hyperemia, a
compensatory vascular increase in blood flow to the occluded area to reestablish
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oxygen blood to ischemic tissues, occurs as a result of the deflation of the pressure cuff
(Pyke & Tschakovsky, 2007). How quickly the vessels react to these changes reveal
the health of the vasculature. Although all three assessment tools evaluate vascular
health, they do so by assessing the vascular reactivity of different types of vessels.
SGP evaluates vascular reactivity of resistance vessels, FMD focuses on conduit
vessels, and PAT assesses vascular function of the microcirculation. To date, there
have been no studies in which vascular function has been evaluated across different
vessel types at rest and following an acute exercise bout.
Abnormalities in the vasodilatory and vasoconstrictive abilities of vessels are a
feature of endothelial dysfunction, a precursor of more serious vascular diseases such as
atherosclerosis, heart disease, and diabetes (Vogel, 2001). Furthermore, it has been
found that endothelial dysfunction is significantly more prevalent in diseased
populations such as patients with Diabetes Mellitus and Coronary Artery Disease
(CAD) (Tagawa et al., 2004), highlighting the need for reliable endothelial dysfunction
evaluation tools for early detection and prevention of cardiovascular disease and other
related illnesses in already vulnerable, unhealthy populations.
Vascular function and its homeostasis require intricate interactions and corelationships amongst different cell types, hormones, vasoactive substances, and it is
affected by diurnal variations. It is imperative to take these relationships into account,
and to control for them during vascular function studies as they may represent
confounding variables. The next few sections will explore in detail the techniques and
measurement issues related to FMD, SGP, and PAT.
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Flow mediated dilation. Brachial artery flow-mediated dilation (FMD) is a frequently
used method which employs high resolution ultrasound to measure brachial artery
diameter (Verma, Buchanan, & Anderson, 2003). FMD measures macrovascular
reactivity and is used to identify subclinical CVD markers in at risk patients (Dhindsa
et al., 2008). Although a trained ultrasonographer is necessary in order to effectively
assess vascular function with FMD, a study found difficulties finding the brachial artery
in only 3% of the population being studied, obtaining FMD values for 97% of the
subjects (Lind, Fors, Hall, Marttala & Stenborg, 2005). Initial scanning of a segment of
the brachial artery at rest provides a baseline vessel diameter which is subsequently
compared to a post-occlusion reactive hyperemic diameter. In addition to producing
reactive hyperemic vasodilation following the pressure cuff release, several studies
have utilized artificial means to induce endothelium-independent vasodilation, such as
the administration of sublingual nitroglycerin as a means of determining maximal
vasodilatory capacity (Lierberman et al., 1996; Lierberman et al., 1994). Although an
efficient method to produce vasodilation, nitroglycerin-induced vasoactivity does not
reflect an individual’s vascular health.
FMD has been found to be a valuable tool in the early detection of
cardiovascular disease risks, and it is considered the gold standard for diagnosing
endothelial dysfunction (Celermajer et al., 1992; Harris, Padilla, Rink, & Wallace,
2006; Peretz et al., 2007). This technique has been successfully used in a vast range of
populations including children and adults in attempts to detect these preclinical
cardiovascular disease precursors (Al-Qaisi, Kharbanda, Mittal & Donald, 2008).
Additionally, FMD has been found to be a promising CVD detection tool in
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asymptomatic patients when reactive hyperemia values stray from expected values for
healthy individuals (Celermajer et al., 1992). In a 2005 study, Lindt et al. compared
FMD to other invasive and non-invasive vascular function assessment tools and
reported average values measured by these techniques in healthy young and healthy
elderly populations. The healthy young group had lower brachial artery diameter and
maximal diameter, and higher diameter change and % FMD when compared to the
elderly healthy group (Lind, Fors, Hall, Marttala & Stenborg, 2005). Noteworthy
values reported in this study for the healthy young group include baseline brachial
artery diameter (3.1 ± 0.5mm), maximal diameter (3.4 ± 0.4mm) and a 9.4% FMD
change representing the percent change in artery diameter at baseline and following the
occlusion. The same study also demonstrated that FMD values decreased with age.
Other important relationships found when investigating the association of FMD in
healthy men were that FMD is directly related to resting wall shear stress, and that a
negative and direct correlation exists between shear stress determinants such as arterial
diameter and flow velocity. (Gnasso, 2001). In epidemiology studies, brachial artery
FMD has consistently demonstrated debilitated vascular functions in subjects exhibiting
cardiovascular disease risk factors. Significantly lower brachial artery FMD was found
in moderately obese pre-pubertal boys without insulin resistance, both at rest and
during exercise. (Karpoff et al., 2009). A subsequent study reiterated the ability of
FMD via ultrasound to detect endothelial dysfunction, as it was found that this method
successfully identified the functional state of the endothelium in patients with
cardiovascular disease risk factors (Atkov, Balahonova & Pogorelova, 1998).
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The addition of exercise as a stressor to the cardiovascular system was assessed
with FMD in several studies. The results indicated that highly endurance-trained
athletes have larger arterial diameter but similar endothelial-dependent vasodilation
when compared to untrained controlled subjects (Rognmo et al., 2008). Additionally, it
has also been reported that NO-dependent vascular mechanisms occur in 45 to 60
seconds in healthy individuals following FMD caused ischemia (Celermajer et al.,
1992), and the response to acute endurance exercise measured by FMD has shown to be
highly dependent on the time following exercise. Obtaining vascular function
assessment in a timely manner is therefore a necessary factor for valid post-exercise
vascular function evaluation.
Although the evidence presented above has shown FMD to efficiently assess
vascular function, studies comparing FMD to other vascular function assessment tools
have found contradictory results. When FMD was compared to increases in forearm
blood flow obtained by SGP, both assessing peripheral vascular endothelial
vasodilatory capacity, it was found that there was no significant correlation between the
two (Eskurza, Seals, DeSouza, Christopher & Tanaka, 2001; Gori at al. 2006). The
reasoning behind this discrepancy was attributed to the different macro and
microvascular properties influencing each technique (Dhindsa et al., 2008). The same
theory was applied to the lack of association between FMD and reactive hyperemic
flow, and FMD and sheer stress, although both factors are known stimuli for FMD
(Dhindsa et al., 2008). On the contrary, a 2007 study found that reactive hyperemia and
FMD were significantly reduced in patients with cardiovascular disease risk factors
(Huang et al., 2007). This method’s reproducibility and repeatability have been
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previously established, and it was found that FMD possesses a very low coefficient of
variation for in vivo measurements for flow mediated dilation (Sorensen et al., 1995)
and a coefficient of repeatability of 4% for baseline brachial diameter measurements
(Rognmo et al., 2008).
While this method is non-invasive and clinically useful, it has several
limitations for clinical use including the significant cost of the equipment and the need
for a trained ultrasonographer. Additionally, the lack of a consistent protocol for the
utilization and interpretation of FMD has also contributed to variations in clinical
findings. For example, a recent study found an 8.9% difference in magnitude of
brachial artery flow mediated dilation following proximal occlusion of the upper arm
versus distal occlusion of the forearm (Peretz et al., 2007). It is therefore warranted to
develop a standard pneumatic cuff occlusion location for the clinical utilization of
FMD. Furthermore, differences in day to day variability in vessel diameter due to
biological circadian rhythms have also been observed (Verma et al., 2003) and a
diurnal effect due to increased sympathetic nervous system activation has been proven
to influence FDM, providing erroneous, decreased readings (Hijmering et al., 2002). It
is important to note that no effects have been found on FMD readings due to repetitive
bouts of reactive hyperemia up to a two hour period; providing flexibility for different
research designs (Harris et al., 2006). Implementation of a new FMD vascular function
assessment protocol should take the previous potential measurement issues into
consideration in order to minimize measurement error.
Strain Gauge Plethysmography. Another common technique to assess vascular
function is strain gauge plethysmography (SGP), which is utilized to evaluate both
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baseline and post-occlusion forearm blood flow. In this method, a pressure cuff is
placed on the upper arm and the wrist. Inflating the proximal cuff creates an upper arm
occlusion (~40 mmHg) and produces sufficient pressure to occlude venous blood
outflow from the limb, yet arterial inflow is unaffected. As arterial blood continues to
enter the limb and venous return is impeded, the volume of the limb increases. The
wrist cuff is inflated to a suprasystolic pressure to prevent blood flow into the hand.
The change in limb circumference is assessed by a mercury-filled strain gauge placed
around the forearm. Following a determination of baseline forearm blood flow, blood
flow is occluded by inflating the upper arm cuff to a suprasystolic values (>200
mmHg). After five minutes of occlusion, the cuffs can be quickly deflated and forearm
blood flow can be assessed during the period of reactive hyperemia. The reactive
hyperemic blood flow response is often quantified as an area under the curve during the
three minute period immediately following release of the upper arm cuff (BousquetSantos, Soares, & Nóbrega, 2005). SGP’s ability to measure vascular function,
reproducibility, and relationships between different physiological findings were
assessed. Mercury-filled SGP was found to be a reproducible vascular assessment tool,
as established by the evaluation of forearm arterial and venous indexes both at rest and
post a 5 minute brachial artery occlusion at 240mm Hg on thee different occasions
(Alomari et al., 2004). Some notable findings regarding physiological relationships
found in the previously mentioned study include the association between handgrip
strength, venous capacitance and outflow; as well as the suggestion of a link between
venous function and exercise performance (Alomari et al., 2004). In agreement to the
general concept that exercise enhances a variety of cardiovascular parameters, baseline
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FBF and vascular reactivity were appreciably improved following an acute maximal
aerobic exercise bout.
Due to the proven reliability of this assessment tool, SGP has been used to test
the assumed physiological effects of various substances on the vasculature. The
nonessential amino acid L-arginine, a precursor to NO, has been found to increase
blood flow in healthy individuals (Campbell, La Bounty & Roberts., 2004) and is being
marketed as a supplement that increases nutrient and oxygen delivery to muscle,
increasing muscle size during and following resistance exercise. Using SGP, it was
found that FBF was unchanged following the ingestion of L-arginine prior to resistance
exercise; contradicting the marketing claims of the vascular enhancement faculties of
L-arginine supplements (Fahs, Heffernan & Fernhall, 2009).
The combination of SGP with other vascular assessment tools has been used in
some clinical studies to assess CVD risk factors. Merging the SGP and FMD
techniques, researchers used brachial artery blood velocity values measured by FMD
and forearm blood flow values determined by SGP to calculate brachial artery diameter
in a young healthy population. A strong correlation was found between the two
methods at rest. Moreover, forearm heating-induced increases in forearm blood flow
and blood flow velocity were accompanied by large increases in brachial artery
diameter (Sinoway, Hendrickson, Davidson, Prophet & Zelis, 1989). Yet when
increases in forearm blood flow were compared to changes in FMD, both assessing
peripheral vascular endothelial vasodilatory capacity, it was found that there was no
significant correlation between the two. (Eskurza, Seals, DeSouza, Christopher &
Tanaka, 2001; Gori et al. 2006). The combination of more than one vascular function
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assessment tool should be further investigated, as it may strengthen CVD diagnostic
and preventive abilities.
Peripheral artery tonometry. More recently, a clinical assessment tool utilizing
peripheral artery tonometry (PAT) technology and marketed under the brand name
Endo-PAT® has been developed to assess microcirculation in the fingers as a means of
evaluating vascular function. This technique utilizes a PAT signal obtained via a
modified plethysmography finger probe that measures blood volume changes before
and after 5 minutes of upper arm occlusion. While there is a significant expense for
the Endo-PAT® unit and the single use finger probes, the use of the unit does not
require extensive expertise or training to operate (Selamet Tierney, 2009). Latex finger
probes are placed on index fingers of both hands and following an initial baseline
assessment, blood flow is assessed for five minutes following a five minute upper arm
occlusion. Since this technique uses a latex finger cuff and assesses blood flow at the
nail bed, PAT cannot be utilized on patients who are either allergic to latex or have long
or acrylic finger nails. According to the manufacturer’s website, a PAT score of 1.67
or lower indicates a need for medical assessment of the cardiovascular system, a score
between 1.68 and 2.0 reflects a need for a reduction of lifestyle CVD risk factors such
as smoking and being overweight, whereas a score of 2.1 or higher signifies a healthy
endothelium (http://www.itamar-medical.com/). A recent study observed acceptable
reproducibility and reliability of the PAT technique with insignificant within-subject
variability in healthy adolescents (Selamet Tierney, 2009).
Endo-PAT has been used to measure endothelial function differences in several
chronic disease populations, including those with high global cardiovascular risk
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(HCVR) and human immunodeficiency virus (HIV). The author’s primary observation
was that patients with HCVR and HIV have diminished endothelial function when
compared to healthy subjects (Ferre, Plana, & Coll, 2007). Several epidemiologic
studies have found that people who work for long shifts are at a heightened risk for
cardiovascular disease due to arterial hypertension, hyperlipedimia and metabolic
syndrome (Knutsson, Jonsson, Akerstedt & Orth-Gomer, 1986; Sookoian et al., 2007;
Suwazono, et al., 2008; Dochi, et al., 2009). More recently, these findings were
confirmed by lower PAT scores in shift workers when compared to non-shift workers,
indicating endothelial dysfunction (Suessenbacher, et al., 2011).
When comparing this technique to the gold standard vascular function
assessment tool, FMD, conflicting results have been found. In a vascular function
assessment tool comparison study, it found that PAT does not have a high correlation
with FMD (Bianchini et al, 2006). In contrast, reduced PAT hyperemia ratios were
consistently observed in endothelial dysfunction patients with reduced brachial artery
FMD (Kuvin et el., 2003) and in healthy patients, higher FMD values were
accompanied by higher PAT hyperemia ratios (Kuvin et el., 2003). As noted in this
study, FMD and PAT have contrasting macro and micro vascular properties, yet these
techniques were found to be strongly associated with each other, challenging the
author’s hypothesis that no correlations were expected between the two tools (Dhindsa
et al., 2008). The evidence presented above suggests that PAT could be a
complementary approach to aid in the detection of patients at risk for CVD, and may
even be used as an alternative method, as PAT is more user friendly than FMD.
The Effects of Exercise on Vascular Function
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A sedentary lifestyle is closely linked to an increased risk for heart disease,
whereas exercise, both aerobic and anaerobic, has been found to produce favorable
outcomes on cardiovascular health. In addition to being a successful cardiovascular
disease preventative measure, exercise can also be a crucial component of cardiac
rehabilitation following myocardial infarction. (Chandrashekhar & Anand, 1991). In
fact, exercise significantly reduces systolic and diastolic blood pressure, which is turn
decreases cardiac mortality rate by 5-9% (Ohkubo et al., 2001).
During exercise, vascular adaptations occur to meet the working muscle's
significantly higher metabolic needs. These adaptations will differ accordingly with
various exercise types and intensities. Some of these adaptations include increased
blood pressure, blood flow and shear stress (Tanaka, H., 2006). Shear stress is the
parallel frictional force that blood applies to the vessel wall as it flows, and it is closely
linked to endothelium dependent vasodilation due to increased NO production
(Woodman, Price, & Laughlin, 2005). Along with an increase in shear stress, dynamic
low-intensity handgrip exercises have been shown to intensify flow mediated dilation
of the brachial artery in healthy subjects further supporting the link between shear stress
and increased vascular function (Mcgowan, C. et al., 2006; Tanaka, H., 2006). In fact,
a linear relationship exists between FMD and shear stress, demonstrating a dose
response depending on the amount of stimulus inflicted by shear stress (Rognmo et al.,
2008). Additionally, Rognmo et al reported a negative correlation between FMD resting
artery diameter; therefore smaller vessels will experience greater shear stress and
greater FMD responses. Furthermore, at the onset of exercise, there is a rapid increase
in blood velocity and therefore blood flow as observed via ultrasound Doppler
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(Shoemaker, Hodge, & Hughson, 1994). Some of these responses are observed only at
specific exercise intensities , as acute moderate-intensity exercise was shown to
increase blood pressure and FBF, while acute mild-intensity exercise did not cause
these changes in young healthy males (Goto et al., 2007). Although this study was
unable to test this relationship during high-intensity exercise due to large body
movements, it was determined that the vasodilation observed during moderate-intensity
exercise occurred due to an increase in NO bioavailability. Exercise induced vascular
improvements have been found to occur throughout the entire vasculature, and are not
limb specific. Enhanced FMD, vascular remodeling and vasodilatory capacity of
conduit and resistance vessels of the upper limbs were reported following
predominantly lower limb exercises (Walther et al., 2008).
Chronic exercise training. The beneficial effects of chronic exercise on vascular
function have been thoroughly studied and are well understood. The advantageous
effects of aerobic exercise include but are not limited to improved oxygen uptake from
working muscle and cardiac output while resistance exercise increases bone density and
muscular strength (Rubattu, 2007). Several studies have observed significant
improvements in vascular health, specifically changes in vessel structure following
endurance and resistance exercise training. Following a 2 hour per day, 6 day
endurance exercise training program, a significant decrease was observed in central and
peripheral arterial stiffness evaluated via peripheral pulse wave velocity (PPWV) in
healthy young males (Currie, Thomas, & Goodman, 2009). Arteries, composed of
elastin and collagen, are prone to lose their elasticity, which negatively affects vascular
function. The significant decreases in arterial stiffness observed in the previously
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mentioned study were due to adaptive responses of the body to a short term exercise
program. Vascular adaptations to long term exercise training have also been evaluated.
Although a 2-year long endurance and strength training program resulted in an
improved cardiovascular risk profile in patients with Diabetes Mellitus (DM), there
were no indications of significant improvement in arterial stiffness (Loimaala et al.,
2009). The observed discrepancy between short-term and long-term exercise training
effects on arterial stiffness may not be due to the length of the exercise program, but
rather the decreased baseline levels of elastin in the vessels of patients with DM
(Loimaala et al., 2009). In a recent study that employed FMD via ultrasound following
an acute bout of resistance exercise on 10 healthy, moderately active men, an increase
in blood flow, therefore in vasodilatory capacity, was detected (Collier et al., 2010). As
shown through these studies, resistance exercise indeed enhances several aspects of
vascular function.
Acute exercise training. More recently, the greater number of studies have evaluated
the effects of acute bouts of exercise, and the results have been inconsistent. Several
studies have found significant improvements in cardiovascular function following a
bout of acute exercise in different diseased and healthy populations. Immediately
following an acute bout of aerobic exercise, it was found that flow mediated dilation
increased in obese patients with impaired vascular function (Zhu et al., 2010) and
impaired microvascular endothelial function was restored by an acute bout of lower
limb exercises in post-surgical varicose vein patients (Klonizakis, Tew, Michaels, &
Saxton, 2009). Acute exercise resulted in a nearly two-fold increase in brachial artery
flow mediated dilation, as well as significant increases in total peripheral conductance
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in healthy sedentary normotensive postmenopausal women, yet these changes were not
observed in premenopausal women ( Harvey et al., 2005). In a more recent study, a
two-fold increase in FBF was observed following a single bout of aerobic exercise, and
a similar increase was seen after a single bout of resistance exercise in a group of
healthy, moderately active young men (Collier et al., 2010). Another recent study
utilized FMD to compare the effects of different intensities of acute exercise bouts on
post-prandial decreases of endothelial function. The study found that moderate
intensity exercise preceding a high-fat meal diminished endothelial dysfunction in
comparison to control subjects who did not endure the single bout of moderate intensity
exercise. In addition, this study found that an acute bout of high intensity interval
exercise exceeded the protective effects of the acute bout of moderate intensity,
significantly increasing flow mediated dilation regardless of the post-prandial lipedemia
(Tyldum, 2009).
As exercise intensity increases, the working muscles, including the heart,
require increased oxygen use and delivery to meet increasing demands. Forearm blood
flow and vascular reactivity have been assessed by SGP in healthy, sedentary subjects
following an acute maximal exercise test, with both FBF and vascular reactivity being
significantly enhanced (Bousquet-Santos, Soares, & Nóbrega, 2005). Moreover,
vascular reactivity was still elevated 60 minutes post-exercise, indicating subacute
effects of a bout of maximal aerobic exercise on vascular function (Bousquet-Santos,
Soares, & Nóbrega, 2005).
Despite the robust evidence of the beneficial effects of acute bouts of exercise
on cardiovascular health, several studies have found opposing results. Acute exercise
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was found to aggravate endothelial dysfunction, marked by a decreased in flow
mediated dilation in patients with intermittent claudication (Sylvestro et al., 2002).
Similar findings marked by a decrease in brachial artery FMD were seen
following an acute bout of isometric handgrip exercises in patients medicated for
hypertension (Mcgowan, C. et al., 2006). It is a strong possibility that the contradicting
findings from the previously mentioned studies may be population and disease specific.
Further investigation of the effects of acute bouts of different intensities on endothelial
dysfunction in healthy, unmedicated populations is clearly warranted.
Acute exercise, although beneficial to cardiovascular health in specific
populations, seems to also be a stressor to the cardiovascular system, aggravating
already existing risk factors and diseases in others (Sylvestro et al., 2002). Application
of this concept in CVD detection and prevention efforts has been successful, and is now
a pivotal part of diagnostic testing. CVD diagnostic testing consisted of testing patients
with an electrocardiogram (EKG) test at rest. EKGs have been the gold standard
diagnostic test for CVD detection as they provide relevant prognostic information such
as cardiac abnormalities including left ventricular hypertrophy, Q waves, ST segment
changes, left bundle branch block, atrial fibrillation, and other factors associated with
CVD (Möhlenkamp, Wieneke, Sack, Erbel, 2007). In fact, performing myocardial
perfusion imaging at rest within 2 to 6 hours of pain chest symptoms detects patient’s
risk level for acute myocardial infarction (Tatum et al., 1997).
As demonstrated above, exercise-induced vascular function alterations vary in
type and magnitude. This is particularly important in diseased populations, which have
shown diminished vascular function following an acute bout of exercise (Sylvestro et al.;
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Mcgowan, et al., 2006). The ability of exercise to stress the cardiovascular system results
in altered vascular responses, which may provide additional prognostic data related to
the health of the vasculature. Moreover, challenging the cardiovascular system to a safe
point may highlight otherwise unseen cardiovascular abnormalities aiding in early
detection of CVD precursors, and even preventing the development of CVD altogether.
Our study attempts to evaluate three commonly used tools that normally evaluate
vascular function at rest, following a moderate intensity acute bout of aerobic exercise. It
is our hope that the additional exercise-induced stress on the cardiovascular system may
further reveal signs of patients with an elevated risk for CVD to decrease their propensity
to development, rather than detect the existence of the disease considered the world’s
largest killers.
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III. ABSTRACT
Background: Endothelial dysfunction (ED) is one of the earliest subclinical indicators
of impaired cardiovascular health and several non-invasive tools have been developed to
evaluate vascular function, including strain gauge plethysmography (SGP), brachial
artery flow-mediated dilation (FMD) via ultrasound, and peripheral artery tonometry
(PAT). While these tools have extensively been studied during a resting condition, the
responses following acute exercise are not as well characterized. Purpose: The purpose
of this study was to compare the pre- and post-exercise vascular function values obtained
with SGP, FMD, and PAT. Relationships among the primary outcome variables obtained
with each assessment tool were also evaluated. Methods: Vascular function was
assessed in 17 sedentary, apparently healthy male subjects (24±4 yrs; 24.5±3.2 kg/m2) at
rest and following an acute submaximal exercise bout with SGP, FMD, and PAT.
Results: During rest, post-occlusion reactive hyperemia resulted in significant (p<0.05)
increases in forearm blood flow (FBF; 2.13±1.03 vs 6.35 ± 2.90 mL/min/100 mL tissue) and
area under the curve (AUC; 226.77 ± 111.20 vs 588.22 ±283.33 mL/min/100 mL) as
determined by SGP. Brachial artery diameter (BAD) as assessed with FMD was
increased by 5.3% (p<0.05). Resting reactive hyperemia index (RHI) as assessed by PAT
was observed to be 1.73±0.34. Significant exercise-induced increases (p<0.05) were
observed in baseline and post-occlusion FBF and baseline AUC values utilizing SGP.
Additionally, FMD baseline blood velocity was significantly increased (91.8±11.1 vs
108.0±17.1 cm/sec, p<0.05) and the PAT augmentation index (AI) was significantly more
negative (-8.8 ±9.4 vs -18.9±8.4%, p<0.05) after exercise. There were no significant

correlations observed among the primary outcome measures obtained from each
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assessment technique. There was, however, a moderate correlation between pre-exercise
vascular reactivity as assessed by SGP and change in blood velocity as assessed by FMD
(r= 0.566, p= 0.035). Conclusions: The addition of an exercise stress to vascular
function assessment may offer greater insight into the health of the vasculature. This
initial study was undertaken to further evaluate the pre- to post-exercise responses
obtained using three commonly employed vascular function assessment techniques in
healthy individuals. Additional research as to the value of the addition of an exercise
stress to vascular function assessment in individuals with traditional cardiovascular
disease risk factors or known cardiovascular disease is warranted.
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VI. INTRODUCTION
The development of cardiovascular disease (CVD) is a gradual process consisting
of morphological and physiological vessel changes that slowly debilitate the vasculature
(Vane, Anggård & Botting, 1990, Quyyumi, 1995). CVD treatment has been thoroughly
investigated, and research efforts have recently shifted to further understanding
prevention as well as early detection of subclinical indicators of CVD, including
endothelial dysfunction (ED). ED is defined as the progressive development of irregular
vascular function, such as abnormal vessel tone, loss of the endothelium’s
atheroprotective properties, and most notably, diminished nitric oxide (NO) availability
(Vane, Anggård & Botting, 1990). NO contributes to vessel homeostasis by regulating
vascular function and mediating endothelium-dependent vasodilation (Verma &
Anderson, 2002). As a precursor of CVD, ED has proven to be treatable and even
reversible by the implementation of drastic lifestyle changes such as smoking cessation,
healthy eating habits and the adoption of an exercise regimen (Chandrashekhar & Anand,
1991).
Exercise has been found to produce favorable outcomes on cardiovascular
health. In fact, exercise significantly reduces systolic and diastolic blood pressure,
which in turn decreases cardiac mortality rate by 5-9% (Ohkubo et al., 2001). Chronic
exercise is linked to an extensive range of health benefits but the effects of acute
exercise are less clear. Supplementary exercise-induced effects include changes in
heart rate and cardiovascular responses such as blood pressure, blood flow, and shear
stress (Tanaka, 2006), which are known to improve following exercise training. The
effects of an acute bout of exercise on these cardiovascular responses have been found
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to vary, and seem to be population and exercise intensity specific (Zhu et al., 2010 &
Sylvestro et al., 2002).
As the prevalence of CVD has dramatically risen in the last several decades (He
& MacGregor, 2009), clinicians have become increasingly interested in obtaining valid
and reliable measures of vascular function as a means of quantifying ED. Several noninvasive assessment techniques have been developed to evaluate vascular function
including flow mediated dilation (FMD), strain gauge plethysmography (SGP), and
peripheral artery tonometry (PAT). These techniques assess vascular function by
evaluating reactive hyperemic responses to a given occlusive stress; however, each
technique evaluates post-occlusion changes in different areas of the vasculature.
Additionally, studies employing these techniques have primarily provided data on
vascular function at rest; however, recent research has also evaluated vascular function
following an acute exercise bout. Some of these findings observed during an acute bout
of exercise include significant increases in brachial artery flow mediated dilation, as
well as significant increases in total peripheral conductance (Harvey et al., 2005) and a
two-fold increase in FBF following a single bout of aerobic exercise (Collier et al.,
2010).
Acute effects of exercise were recently investigated in post-surgical varicose
vein patients with ED. The study found that impaired microvascular endothelial
function was restored by an acute bout of lower limb exercises (Klonizakis, Tew,
Michaels, & Saxton, 2009). Despite the robust evidence of the beneficial effects of
acute bouts of exercise on cardiovascular health, several studies have found conflicting
results. Acute exercise was found to aggravate endothelial dysfunction, marked by a
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decreased in flow mediated dilation in patients with intermittent claudication (Sylvestro
et al., 2002). Similarly, findings marked by a decrease in brachial artery FMD were
observed following an acute bout of isometric handgrip exercises in patients medicated
for hypertension (Mcgowan, C. et al., 2006). The discrepancies observed may be
population specific, as diminished vascular function following exercise seems to be
more predominant in diseased populations.
The augmented stress induced on the cardiovascular system by exercise is the
basis for including graded exercise testing as a means of detecting CVD (Lear, Brozic,
Myers & Ignaszewski, 1999). As with traditional cardiovascular exercise testing, the
inclusion of exercise as a stressor during assessment of vascular function with tools such
as SGP, FMD and PAT may aid in the recognition of early signs of CVD development
and other cardiovascular abnormalities otherwise undetected by assessment at rest.
However, there is currently no consensus on which assessment tool is most appropriate
for a pre- and post-exercise evaluation of vascular function. Therefore, the purpose of
this pilot study was to evaluate pre- and post-exercise reactive hyperemic responses
utilizing three common vascular function assessment tools: SGP, FMD, and PAT.
Additionally, this study sought to evaluate the relationships among the primary outcome
variables associated with each technique both before and after an acute bout of moderate
intensity aerobic exercise.
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VII. METHODS

Subjects. Apparently healthy sedentary subjects aged 19-35 years with body mass index
(BMI) values <30 kg/m2 were recruited to participate in the study. Subjects were asked
to attend three research trials (SGP, FMD and PAT); randomly assigned with at least 48
hours in between trials, to assess vascular function both at rest and following 20 minutes
of moderate intensity aerobic exercise. All subjects voluntarily participated in the study
and gave written informed consent. Each subject completed a brief medical history
questionnaire and the short form of the International Physical Activity Questionnaire
(IPAQ-short) prior to beginning the study. Upon arriving for each trial, each subject’s
weight was obtained to the nearest 0.25 kg and height was obtained to the nearest 0.25
cm. Subjects were subsequently placed in a supine position for a minimum of 30 minutes
prior to any assessments. Subjects were instructed not to consume food after midnight the
night before participating in each trial, although moderate water consumption was
allowed until the time of the trials. Additionally, subjects were asked to refrain from
alcohol and tobacco consumption for a minimum of 24 hours, and to refrain from
exercise for a minimum of 48 hours prior to each trial. All procedures were approved by
the VCU Institutional Review Board
Exclusion Criteria. Exclusion criteria for this study included any history of
cardiovascular or metabolic disease, or if the subject was taking any medication that
might affect cardiovascular hemodynamics, vascular function, or vascular responses to
exercise. Females were excluded from this pilot study as varying hormone
concentrations during the phases of the menstrual cycle have been shown to alter vascular
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function (Deroo & Korach, 2006). Subjects were also excluded if they had a latex allergy
since the assessment of vascular function with the PAT unit requires contact with an
inflatable finger cuff made from latex. Lastly, since exercise training is thought to alter
vessel structure and possibly vascular function, the current study sought to recruit
subjects that did not meet the Surgeon General’s recommendation of 30 minutes of
moderate intensity physical activity 5 days per week as determined by the IPAQ-short.
Assessment of Vascular Function
All vascular function measurements were performed in the morning (~7:00 AM),
in a quiet environment and at controlled ambient temperatures both at rest and following
a 20 minute bout of submaximal exercise.
Strain-gauge plethysmography. Forearm blood flow was assessed using mercury-inrubber strain-gauge plethysmography (SGP; Model AI6, D.E. Hokanson, Inc., Bellevue,
WA). Methods utilized for forearm blood flow measures were similar to those previously
reported by Bousquet-Santos et al. (2005). A pressure cuff was placed around the upper
right arm. A smaller wrist pressure cuff was placed around the right wrist to occlude
hand circulation. A mercury-filled strain gauge was placed around the widest part of the
forearm, 10 cm distal to the olecranon process. The arm was supported by foam supports
at a level approximately 10° above the heart. Electrodes were placed on the subject’s
chest for electrocardiogram (ECG) acquisition. Baseline forearm blood flow (FBF)
measurements were taken by inflating the wrist cuff to 250 mmHg and then rapidly
inflating the upper arm cuff to 40 mmHg for 4-s to occlude venous outflow, followed by
an 8-s deflation, during each 12-s cycle. Nine cycles were recorded to determine the
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue
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volume/min). Following baseline measures, the upper cuff was inflated to 240 mmHg for
5 minutes to occlude blood flow and subsequently induce reactive hyperemia. Upon cuff
deflation, FBF was measured for another nine cycles. FBF trials were analyzed using the
Hokanson AI6 Software version 2.2.4, and subsequently exported to a spreadsheet for
further analysis. The values obtained at rest and following the acute submaximal exercise
bout included baseline and hyperemic FBF (ml/100 ml of forearm tissue volume/minute),
area under the curve (AUC), and vascular reactivity. AUC was calculated by the addition
of the averages of every two consecutive FBF values over the 12 second cycle time
frame. Vascular reactivity was calculated as the difference between AUC at baseline and
during reactive hyperemia.
Flow mediated Dilation. Brachial artery diameter was assessed with high resolution
ultrasound (HDI 5000, Phillips ATL; Oceanside CA) utilizing methods similar to those
previously reported by Peretz et al. (2007). Approximately 15 minutes prior to the trial, a
resting blood pressure measurement was obtained from the left arm. For the FMD trial,
the right arm was comfortably placed in an extended position to allow for ultrasound
scanning of the brachial artery at a location above the antecubital fossa. A pressure cuff
was placed around the subject’s forearm and ECG electrodes were placed on the subject’s
chest to obtain a corresponding ECG signal for synchronization of diameter
measurements with the R-wave of the cardiac cycle. All baseline and post-occlusion
trials were recorded to Super VHS videotape for later analysis. A longitudinal section of
the brachial artery was located by a trained ultrasonographer and baseline brachial artery
diameter and baseline Doppler blood velocity were recorded. Following the baseline
measures, the forearm pressure cuff was inflated to 240 mmHg for five minutes to
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occlude blood flow. At the end of the five minute occlusion period, the cuff pressure was
quickly released and peak reactive hyperemic blood velocity was assessed and recorded
for approximately 30 seconds. After 45 seconds, the assessment mode was quickly
changed to record images of the vessel diameter for the next 2 minutes to obtain peak
diameter during reactive hyperemia.
WinDVR software (InterVideo, Inc.) was utilized to capture baseline and postocclusion images for analysis. Images for analysis of brachial artery diameter and blood
flow velocity were captured at the end of diastole at the peak of the ECG R wave.
Vascular regions of interest were delineated at the intima-lumen interface for brachial
artery diameter measurements employing software developed by the Clinical Research
Center (CRC) at Virginia Commonwealth University. Values obtained from each trial
included baseline brachial artery diameter, 1 minute post-occlusion brachial artery
diameter, average baseline blood velocity, and peak reactive hyperemic velocity. FMD
was calculated by dividing the post-occlusion diameter change by the baseline diameter
and expressed as the brachial artery diameter percent change [((maximal reactive
hyperemic diameter – baseline diameter)/baseline diameter)*100]. Lastly, reactive
hyperemic blood velocity change was calculated by dividing the post-occlusion blood
velocity change by the baseline blood velocity [((maximal reactive hyperemic blood
velocity – baseline velocity)/baseline velocity)*100]. Each assessed value was obtained
by averaging 5 baseline and 5 post-occlusion images.
Peripheral Artery Tonometry. Pulsatile blood volume changes in the fingers were
determined with peripheral artery tonometry (Endo-PAT2000, Itamar Medical). Methods
utilized for determination of vascular function with PAT were similar to those previously
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reported by Selamet and Tierney (2009). A pressure cuff was positioned around each
subject’s upper right arm and non-invasive pneumatic latex finger cuffs were placed on
the right and left index fingers. Pulse wave amplitude was continuously recorded from
both fingers. The finger cuffs were inflated and one minute of measurement of pulsatile
changes were evaluated to ensure the absence of leaks in the cuffs. Subsequently,
baseline measurements were obtained for 5 minutes in both the right and left index
fingers. The pressure cuff was subsequently inflated to 240 mmHg to occlude blood flow
for 5 minutes. Pulsatile flow was continuously assessed during the 5 minute occlusion
period to ensure adequate occlusion of blood flow. Following the 5 minute occlusion
period, the cuff was rapidly deflated and the pulsatile blood flow response to reactive
hyperemia was assessed for an additional 5 minutes. The EndoPAT™ automatic analysis
software was utilized to obtain the reactive hyperemic index (RHI) and the augmentation
index (AI) for each trial. The RHI is the ratio of the average pulse wave amplitude
measured over 60 seconds, starting one minute after cuff deflation, to the average pulse
wave amplitude measured at the baseline (Syvänen, Korhonen, Partanen, & Aarnio,
2010). According to the Itamar Medical Manager of Cardiovascular Development,
AI indicates the elasticity of the tunica media, an independent risk factor for CVD
(Tirosh, R, personal communication, July 11, 2011). In addition, each trial was analyzed
by manually selecting baseline, occlusion, and test areas as detailed by Selamet and
Tierney (2009). Any extraneous artifact was also marked, if present. Test over baseline
ratios (T/B) for both test and control arms were calculated by the EndoPAT2000™
software. The test arm ratio was subsequently normalized to accommodate any changes
in the control arm during the trial.
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Submaximal Exercise Bout. Following the pre-exercise assessment of vascular function,
each subject participated in a 20 minute submaximal bout of treadmill exercise. The
exercise began with a three minute warm up at 3.0 MPH and 0% grade. Following the
brief warm up, the treadmill speed and grade was set to a workload that would elicit a
heart rate equal to 75% of the subject’s age-predicted maximum heart rate for the 20
minute exercise bout. Heart rate was continuously monitored throughout the exercise
bout and minor adjustments in speed and/or grade were made and noted during the first
trial. Subsequent trials utilized the same speed and grade to equate the workloads
between the three vascular function trials. Upon completion of the 20 minute exercise
bout, subjects were instructed to cool down for three minutes at 3.0 MPH, and 0% grade.
Participants were immediately taken to an examination room for post-exercise vascular
function measures. All post-exercise vascular function measures were commenced
within 10 minutes of completion of the exercise bout.
Statistical Analysis. All data are represented as mean ± standard deviation. Paired
samples t-tests were employed to compare baseline and post-occlusion means before and
after exercise for each measure and pre- and post-exercise means for each vascular
function measure. Additionally, Pearson Product Moment Correlations were employed to
determine relationships among pre- and post-exercise values obtained from each
assessment tool. The α-level was set at p < 0.05 for all statistical analyses.
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VIII. RESULTS
Subjects
Seventeen apparently healthy sedentary male subjects (24 ± 4.14 years; 24.5 ± 3.23
kg/m2) voluntarily participated in the study and underwent testing with SGP, FMD and
PAT prior to exercise and following a moderate-intensity acute bout of aerobic exercise.
Subject population characteristics are presented in Table 1.
Effects of exercise on hemodynamic measures
Average heart rate during the 20 minute exercise bout was 148 ± 2 beats/min. There were
significant increases in mean arterial pressure (86.8 ± 9.98 mmHg vs 91.8 ± 2.34 mmHg;
p < 0.003), systolic blood pressure (117.47 ± 7.4 mmHg vs 124.35 ± 8.61mmHg; p <
0.006) and diastolic blood pressure (71.71 ± 12.72 mmHg vs 75.76 ± 11.87 mmHg; p <
0.014) from pre- to post-exercise. Additional hemodynamic measures are found in Table
1.
Strain Gauge Plethysmography
Pre-exercise. SGP data were obtained on 15 subjects. Data from 2 subjects were
excluded from the analysis due to equipment failure during one or more of the reactive
hyperemia trials. Significant differences were observed between baseline FBF and postocclusion FBF (2.13 ± 1.03 mL/min/100 mL tissue vs 6.35 ± 2.90 mL/min/100 mL; p=
0.005) representing reactive hyperemia-induced changes (Figure 1). Additionally, the
calculated post-occlusion AUC values were significantly greater compared to baseline
AUC values (226.77 ± 111.20 mL/min/100 mL vs 588.22 ± 283.99 mL/min/100 mL ; p<
0.0001). Pre-exercise vascular reactivity (VR) was determined to be 355.26 ± 203.39
mL/min/100 mL.
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Post-exercise. During the post-exercise SGP trial, post-occlusion FBF values were
significantly greater than baseline post-exercise values (3.0 ± 1.03 mL/min/100 mL tissue
vs 7.61 ± 2.77 mL/min/100 mL; p< 0.0001) representing reactive hyperemia (Figure 1).
Post-occlusion AUC values were also significantly greater than baseline values
(375.34 ± 107.08mL/min/100 mL vs 703.71 ± 283.16 mL/min/100 mL ; p< 0.0001).
Lastly, post-exercise VR was observed to be 366.68 ± 210.79 mL/min/100 mL.
Pre- to post-exercise changes in SGP. Pre- and post-exercise baseline and post-occlusion
SGP values are provided in Figure 1. After exercise, baseline FBF was significantly
greater than the pre-exercise baseline FBF (3.00 ± 1.03 mL/min/100 mL tissue vs 2.13 ±
1.03 mL/min/100 mL tissue; p= 0.012), and post-exercise post-occlusion FBF was also
significantly greater than its pre-exercise counterpart (7.61 ± 2.77 mL/min/100 mL tissue
vs 6.35 ± 2.90 mL/min/100 mL tissue; p= 0.002). Additionally, post-exercise baseline
AUC was significantly greater than pre-exercise baseline AUC (p= 0.008) however, there
was no significant difference observed between pre- and post-exercise post-occlusion
AUC values and the calculated pre- and post-exercise VR were not significantly
different. Pre-exercise post-occlusion FBF was significantly correlated to post-exercise
post-occlusion FBF (r= 0.763, p=0.002) and post-exercise post-occlusion maximum FBF
(r= 0.753, p=0.003). A significant correlation between pre-exercise and post-exercise
post-occlusion maximum FBF was also observed (r= 0.826 p= 0.001). Additionally, preexercise VR correlated with post-exercise VR (r= 0.742, p= 0.004), as well as pre and
post-exercise post-occlusion AUCs (r= 0.745, p= 0.002).
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Flow Mediated Dilation
Pre-exercise. Pre-exercise FMD data were obtained on 16 subjects. One subject was
excluded due to equipment malfunction during the pre-exercise FMD trial. Baseline
brachial artery diameter and average blood velocity was determined to be 4.178 ± 0.37
mm and 91.839 ± 11.126 cm/sec, respectively. As expected during post-occlusion
reactive hyperemia, there was a 5.3% increase in brachial artery diameter (p< 0.0001)
(Figure 2) and a 71.9% increase in blood velocity (p< 0.0001). Pre-exercise FMD
measure correlations are found in Table 3.
Post-exercise. Similar to the pre-exercise trial, there was a significant (p< 0.0001)
increase of 4.9% in brachial artery diameter after the 5 minute occlusive stress (Figure 2).
Post-exercise vascular measure correlations obtained with FMD can be found in Table 3.
Pre- to post-exercise changes in FMD. There were no significant differences observed
between values obtained for baseline brachial artery diameter, post-occlusion brachial
artery diameter, FMD percentage, or post-occlusion reactive hyperemic blood velocity
during the pre- and post-exercise trials. Post-exercise baseline blood velocity was,
however, significantly (p< 0.0001) greater than pre-exercise values. Pre- and postexercise vascular function measures obtained by FMD are found in Figure 2. A strong
positive correlation was found between baseline BAD values pre- and post exercise (r=
0.976; p< 0.0001) as well as between pre- and post-exercise post-occlusion BAD values
(r= 0.956, p< 0.0001). The correlation coefficient between pre-exercise and post exercise
FMD was 0.753 (p= 0.001). Correlation data for FMD measures are included in Table 3.
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Peripheral Artery Tonometry
Pre-exercise. PAT data were obtained on 16 subjects. The data for one subject was
excluded due to an equipment malfunction. Pre-exercise RHI values were determined to
be 1.73 ± .34. Manual calculation of the RHI value resulted in a slightly lower mean
value of 1.32 ± 0.335. Mean AI value at rest was found to be -8.77 ± 9.35%.
Post-exercise. Post-exercise RHI values were determined to be 1.55 ± 0.191. Manual
calculation of the post-exercise RHI value resulted in a mean value of 1.10 ± 0.29. Mean
AI value following exercise was determined to be -18.92 ± 8.41%.
Pre- to post-exercise changes in PAT. There was no significant difference observed
between the computer-determined RHI values obtained pre- and post-exercise. There
was, however, a pre- to post-exercise significant difference (p= 0.022) in the manuallycalculated RHI values. Additionally, there was a significant difference observed in the
AI values (p<0.001). Significant correlations were observed for AI values obtained at
rest and AI values after exercise (r=0.627, p= 0.022).
Relationships among Vascular Assessment Tools
There were no significant correlations observed among the primary outcome measures
obtained from each assessment technique. There was, however, a moderate correlation
between pre-exercise VR as assessed by SGP and pre-exercise change in blood velocity
as assessed by FMD (r= 0.566, p= 0.035). Correlations between measures obtained by
SGP, PAT and FMD are included in Table 4.
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IX. DISCUSSION

The endothelium plays a central role in the preservation of vascular homeostasis.
In fact, an impaired endothelium is the initial manifestation of CVD development,
occurring long before any of the well-recognized epidemiologic characteristics of the
onset of the disease (Wilson, 2005). Although several endothelial function assessment
tools have been developed, they are yet to be fully evaluated as valid tools for the early
detection of CVD (Peretz et al., 2007; Gori et al., 2006 & Selamet Tierney, 2009). In this
pilot study, inter-relationships among different vascular function techniques were
evaluated on the same subjects prior to exercise and following an acute bout of moderate
intensity exercise. While all three techniques (FMD, SGP and PAT) in this study have
been developed to assess vascular function following blood flow occlusion and
subsequent post-ischemic reactive hyperemia, each technique functionally evaluates a
different component of the vasculature to provide an indication of vascular health.
In contrast to the thoroughly investigated effects of chronic exercise on vascular
function, research on the effects of an acute bout of exercise on vascular hemodynamics
is sparse. In the current study, we have observed increases in forearm blood flow,
forearm blood flow area under the curve, brachial artery diameter, and blood velocity
both before and after an acute bout of moderate intensity aerobic exercise in response to a
5 minute occlusive stress. Additionally, we found significant differences between preexercise and post-exercise values for baseline forearm blood flow, baseline forearm blood
flow area under the curve, and post-occlusion forearm blood flow values obtained from
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SGP. Moreover, we observed an increase in baseline blood velocity as assessed by FMD,
as well as a decrease in AI% as assessed by PAT. Lastly, we found no significant
correlations among the primary outcome measures obtained from SGP, FMD, and PAT
either before or after exercise.
Pre-exercise vascular function. Pre-exercise vascular function values obtained from each
method are similar to those previously reported (Alomari et al., 2005; Peretz et al., 2007
& Bonetti et al., 2004). Pre-exercise SGP resulted in increased FBF and AUC values
following a 5 minute occlusion when compared to their baseline counterparts. AUCs
were calculated as a flow-time index. These findings are comparable to those of Alomari
et al., who found similar increases in post-occlusion FBF in repeated trials, as well as
those of Bousquet-Santos et al, which measured FBF pre- and post-exercise (Alomari et
al., 2005; Bousquet-Santos & Soares, Nobrega, 2005).
Pre-exercise flow mediated dilation via ultrasound revealed significant increases
in blood velocity and BAD values following the 5 minute occlusive stress. These results
are in agreement with those of Peretz et al., who found significant increases from baseline
BAD to post-occlusion BAD during a resting condition using both upper-arm and
forearm occlusion (Peretz et al., 2007). Comparing our results to those reported by other
similar studies, we found that BAD values for our study seem to be slightly higher, yet
our FMD values are lower than FMD reported by others (Harvey et al., 2005; Aizer et al.,
2009, Okamoto, Masuhara & Ikuta, 2007; Rogmo et al., 2008). Larger brachial artery
diameters were obtained with forearm occlusion than upper arm occlusion. Distal
occlusion has been recommended over proximal occlusion, as it produces a dilatory
response mainly dependent on NO.
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Vascular function assessment by PAT does not produce separate baseline and
post-occlusion values. Rather, the system software automatically calculates a reactive
hyperemia index (RHI) as well as an augmentation index (AI). Additionally,
test/baseline (T/B) ratios can be calculated by the system software following the manual
demarcation of baseline, occlusion and test areas for both the control and the test
(occlusion) arms. Significant differences were found between T/B1 (test arm) and T/B2
(control arm) reflecting reactive hyperemia-induced vascular changes. The mean resting
RHI value in the current study was found to be 1.73 ± 0.34, values which reflect a healthy
endothelium as expected from an apparently healthy population. These values are similar
to those found by Bonetti et al., who reported a RHI value of 1.78 ± 0.08 in subjects with
normal coronary endothelial function (Bonetti et al., 2004). The average pre-exercise AI
value, which represents vessel elasticity, was -8.769 ± 9.347. While very few studies
have measured AI, this measure may become a variable of greater interest for future
studies, as AI is considered an independent CVD risk factor (Tirosh, R, personal
communication, July 11, 2001).
Post-exercise vascular function. Post-exercise vascular function responses as detected by
the SGP, FMD and PAT were variable in comparison to pre-exercise values. As
observed during pre-exercise measurements, significant increases were also observed in
FBF and FBF AUC values as assessed by SGP from baseline to post-occlusion following
the acute exercise bout. These findings are similar to those of Bousquet-Santos et al.,
who also observed significant increases in baseline and post-occlusion blood flow
following exercise. However, in contrast to their findings that reported an augmentation
in VR shortly after, and 60 minutes after exercise, we did not observe a significant
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increase in this value. As previously mentioned, AUC represents a flow-time index
calculated from baseline and post-occlusion FBF measures respectively. Specifically,
AUC is calculated by adding the means of each pair of two consecutive FBF measures,
each pair which has been divided by the length of each cycle (12 seconds). Elevations in
FBF due to exercise will in turn result in elevated AUC values. Due to this elevation
following exercise, non-significant differences in VR are not entirely surprising since
augmentations in AUC will in turn decrease post-exercise VR values. Although the SGP
methodology of the current study was modeled after the technique of Bousquet-Santos et
al., their exercise intervention consisted of an acute bout of maximal rather than moderate
intensity exercise. The difference in exercise intensities between the two studies may be
the cause of the discrepancy in VR findings, as higher exercise intensities are known to
cause greater acute vascular responses (Harris, Padilla, Hanlon, Rink & Wallace, 2008).
Significant increases in post-occlusion BAD and velocity from their respective
baseline values were detected by FMD following exercise. These findings are in
agreement to those of Harvey et al., in which vascular function was assessed in postmenopausal women (Harvey et al., 2005). Unlike Harvey et al., we found no statistical
significance in the difference between resting and post-exercise values for BAD, FMD
and also post-occlusion blood velocities. In addition to the previously mentioned study,
other studies that reported significant increases in BAD and improvements in FMD
following similar exercise protocols in diseased and healthy populations (Padilla et al.,
2009, & Zhu et al., 2007). In contrast, other studies revealed that acute exercise was
found to aggravate endothelial dysfunction, marked by a decreased in flow mediated
dilation in patients with intermittent claudication (Sylvestro et al., 2002). Similar
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decreases in brachial artery FMD were seen following an acute bout of isometric
handgrip exercises in patients medicated for hypertension (Mcgowan, C. et al., 2006).
Although these discrepancies may be population or disease specific, further investigation
of NO-dependent vasodilation responses after exercise is certainly warranted.
Additionally, standardization of FMD methodology is of paramount importance in order
to allow comparisons among published studies.
Analysis of the post-exercise data obtained via PAT revealed significantly
different values in AI but not in RHI. The post-exercise mean AI% value was found to
be -18.923 ± 8.411%, a value indicative of healthy, elastic vessels. T/B1 representing
the occluded arm was slightly higher than the T/B2 ratio for the control arm,
demonstrating the effects of blood flow occlusion. The T/B ratios have no clinical value
but are have been utilized for research purposes to look at changes in blood flow in
comparison to the control arm. Comparing pre-exercise to post-exercise values obtained
by PAT revealed statistically significant differences between resting and post exercise
T/B1 ratios of the test arms, reflecting altered reactive hyperemic responses to exercise.
This significance was not observed between pre-exercise and post-exercise T/B2 ratios
for the control arm. Interestingly, RHI values were lower following exercise, denoting
endothelial dysfunction. There have been no studies assessing vascular function with
PAT at rest and following exercise.
To our knowledge, there have been no studies comparing all three vascular
function assessment tools pre and post-exercise. However, there have been several
studies comparing different combinations of two of these tools both during a resting
condition (pre-exercise) and following different exercise protocols. Unlike a limited
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number of previous studies, we found no significant correlations among the primary
outcome measures obtained from each assessment technique. Strong correlations were
found between SGP and FMD in a study that utilized FBF and forearm volume to
calculate diameter changes in the brachial artery (Sinoway, Hendrickson, Davidson WR
Prophet & Zelis, 1989). These calculations were made under the assumption that blood
that reaches the forearm travels mostly through the brachial artery. No such correlations
were observed in our study prior to or after exercise. We did, however, find a moderate
correlation between pre-exercise VR and pre-exercise changes in blood velocity as
assessed by FMD. Our lack of correlation in vascular function measures by SGP and
FMD has been supported by previous research. For example, when FMD was compared
against SGP during a resting condition, it was found that there was no significant
correlation between the two (Eskurza, I., Seals, D., DeSouza., Christopher A &Tanaka,
H.,2001; Gori at al. 2006). A major difference between this study and the current study is
the use of intrabrachial artery infusion of acetylcholine, commonly known for its
vasodilatory properties as a stimulus for FBF. Although both methods assess peripheral
vascular endothelial vasodilatory capacity, each method gauges vascular function of
distinct vessel types, dictated by unique molecular mechanisms. NO controls vasoactivity
of conduit vessels (FMD) via endothelial cells, yet FBF of the resistance vessels is
partially (≈ 50%) controlled by smooth cells (Ferrara, et al., 2006).
Conversely, PAT evaluates the microcirculation of capillary networks. The
differences in molecular mechanisms dictating vascular reactivity of different vessel
types may explain the lack of significance in correlation analysis found in our study. In
a comparison study, Bianchini et al. reported no correlation between vascular function
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values obtained via PAT and FMD (Bianchini et al, 2006). However, Dihndsa et al,
whose population was very similar to ours, found PAT and FMD to be strongly
associated with each other (Dhindsa et al., 2008).
Several factors have been shown to influence the vascular function values
obtained from the assessment tools employed in this study. These include the state of
the vascular health of the population evaluated, methodology differences, and whether
these assessments are performed at rest or following exercise (Harris, Padilla, Hanlon,
Rink & Wallace, 2008; Gori at al. 2006; & Sylvestro et al., 2002). If post-exercise
assessment is being performed, exercise intensity and the length of the exercise bout may
be features worth further investigation.
Our results must be interpreted within the context of several study limitations.
First, our population size was small, thereby limiting statistical power. Additionally, our
population consisted of young, sedentary and apparently healthy individuals. In such
populations, one can expect cardiovascular systems free of exercise-induced training
effects, age-related deterioration, and disease. These characteristics are not representative
of the general public, and thus may limit our ability to apply these findings. The use of an
apparently healthy population in this pilot study limits the variability of vascular
measures, reducing the likelihood of obtaining statistically significant differences. As
SGP, FMD and PAT are manufactured to detect subclinical vascular abnormalities such
as ED, future studies will benefit from the inclusion of a population possessing CVD risk
factors to compare against a control population such as ours. Another noteworthy factor
to consider is the exercise intensity required for significant vascular responses to occur,
particularly in an apparently healthy population. Acute moderate-intensity exercise was
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shown to increase blood pressure and FBF, while acute mild-intensity exercise did not
cause these changes in young, healthy individuals (Harris, Padilla, Hanlon, Rink &
Wallace, 2008). Incorporating an exercise bout of higher intensity than the submaximal
exercise bout used in our study may intensify exercise-induced vascular responses. The
additional stress that higher intensity exercise applies to the cardiovascular system may
improve the effectiveness of endothelial dysfunction assessment with SGP, FMD and
PAT in apparently healthy individuals. Alternatively, exercising the limb being assessed
may yield more relevant vascular function findings. Limb specific exercises such as
handgrip exercises have previously been successfully employed in the assessment of
vascular function, and may be a worthy addition to the current study’s methodology
(McGowan et al., 2006). Although exercise is an effective addition to CVD diagnostic
testing, as employed during stress tests, more specific exercise intensity parameters may
be needed when attempting to detect pre-cursors in individuals without overt disease.
In this pilot study, reactive hyperemic vascular responses were investigated both
before and after a submaximal aerobic exercise bout with SGP, FMD and PAT in a
sedentary, apparently healthy population. Pre-exercise vascular responses were mostly
similar to those found by other studies with similar populations; however, we observed
variable responses in post-exercise measures. Exploring relationships among the
vascular measures assessed by SGP, FMD and PAT before and after exercise may
provide a more comprehensive insight into exercise-induced effects on the vasculature.
Gaining an understanding of expected vascular responses for healthy individuals will aid
in providing a foundation for vascular response evaluation of individuals with CVD risk
factors and diseased populations. In our study, no correlations between the three tools
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were found at rest and following exercise. Future research should consider the addition of
populations at different CVD risk levels, as well as populations formally diagnosed with
CVD to further investigate the diagnostic power and clinical use of an exercise stressor in
conjunction with SGP, FMD and PAT to improve ED detection and CVD prevention.
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X. TABLES
Table 1. Subject Demographics
Variable

Mean (±sd)

N
Age (years)
Height (cm)
Weight (kg)
BMI (kg/m2)
Resting Systolic BP (mm Hg)
Resting Diastolic BP (mm Hg)
Resting MAP
Post-exercise MAP
Post-exercise Systolic BP (mm Hg)
Post-exercise Diastolic BP (mm Hg)
Exercise HR (bpm)

17
24.1 ±
182.5 ±
81.5 ±
24.5 ±
117.5 ±
71.7 ±
86.81 ±
91.80 ±
124.4 ±
75.8 ±
148 ± 2

4.14
6.93
10.37
3.23
7.40
12.72
9.98
9.58
8.61
11.87

Abbreviations: BMI, body mass index; BP, blood pressure; HR, heart rate; MAP, mean arterial pressure

Table 2. Pre and Post-exercise vascular function measures obtained from each of the three
assessment tools

Measure
SGP (N= 15)
Baseline FBF (mL/min/100 mL tissue)
Post-Occlusion FBF (mL/min/100 mL tissue)
Baseline AUC
Post-Occlusion AUC
VR
FMD (N= 16)
Baseline BAD (mm)
Post-Occlusion BAD (mm)
FMD (%)
Baseline Blood Velocity (cm/sec)
Post-Occlusion Blood Velocity (cm/sec)
PAT (N= 16)
RHI
AI (%)

Pre-Exercise

Post-Exercise

2.13
6.35
226.77
588.22
355.26

±
±
±
±
±

1.03
2.90
111.20
283.33
203.39

3.00
7.61
375.34
703.71
366.67

4 .178
4.397
5.33
91.839
160.067

±
±
±
±
±

0.376
0.376
3.02
11.126
21.39

1.73 ± 0.34
-8.77 ± 9.35

1.03*
2.77 *
107.08*
283.16 *
210.79 *

4.188 ± 0.399
4.387 ± 0.374
4.88 ± 2.99
108.00 ± 17.09 *
172.73 ± 27.37
1.55 ± 0.19
-18.92 ± 8.41*

Abbreviations: BAD, brachial artery diameter; FMD, flow mediated dilation; RHI, reactive hyperemic index; AI,
augmentation index; FBF, forearm blood flow; AUC, area under the curve; VR, vascular reactivity. *p< 0.05
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±
±
±
±
±

Table 3. Correlation between vascular measures as assessed by FMD
PE FMD
PR FMD

0.753**
(P< 0.001)

PE BL BAD

PE PO BAD

-

PR PO BAD

-

-

PR BL BAD

-

0.976**
(P< 0.000)

0.917**
(P< 0.000)

0.944**
(P< 0.000)

PR PO BAD

-

0.943**
(P< 0.000)

0.956**
(P< 0.000)

1

Abbreviations: PR, pre-exercise; PE, post-exercise; BL, baseline; PO, post-occlusion; post-exercise; BV, blood
velocity ; FMD, flow-mediated dilation ; BAD, brachial artery diameter.
*P< 0.05; ** P< 0.01

Table 4. Correlation between vascular measures as assessed by SGP, FMD and PAT

PR VR
PE AI
PE RHI
PE VR

PR VL
0.566*
(P< 0.035)
-

PE FMD
0.564*
(P< 0.045)
-

- 0.272
(P< 0.346)
0.511
(P< 0.074)

0.000
(P< 0.999)
0.087
(P< 0.788)

Abbreviations: PR, pre-exercise; PE, post-exercise; BL, baseline; PO, post-occlusion; post-exercise; VR, vascular
reactivity ; VL, blood velocity ; FMD, flow-mediated dilation AUC, area under the curve.
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XI.FIGURES
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Figure 1. Changes between baseline and post occlusion FBF pre and post-exercise
* = post-occlussion significance, p< 0.05
# = post-exercise significance, p< 0.05

4.9

*

4.8

*

4.7
4.6
4.5

BAD (mm)

4.4
4.3
4.2
4.1
4
3.9
3.8
Pre-Ex Baseline BAD

Pre-Ex Post-Occlusion BAD

Post-Ex Baseline BAD

Post-Ex Post-Occlusion BAD

Figure 2. Pre and Post-Exercise Changes in Baseline and Post-Occlusion BAD
* = post-occlusion significance, p< 0.05
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RESEARCH SUBJECT INFORMATION AND CONSENT FORM

TITLE: A PRE AND POST EXERCISE COMPARISON OF THREE ASSESSMENT TOOLS
COMMONLY EMPLOYED TO EVALUATE VASCULAR FUNCTION

VCU IRB PROTOCOL NUMBER:
INVESTIGATORS: Ronald K. Evans, Ph.D., Lorena P. Salom, B.S.
SPONSOR:
This consent form may contain words that you do not understand. Please ask the study
staff to explain any words or information that you do not clearly understand. You may
take home an unsigned copy of this consent form to think about or discuss with family or
friends before making your decision. In this consent form, “you” always refers to the
subject.
PURPOSE OF THE STUDY
The purpose of this study is to compare three different types of equipment that are commonly
used to measure how blood vessels function by either measuring blood flow or changes in vessel
size. We will be taking these measures while you are at rest and after 20 minutes of moderate
intensity exercise on a treadmill.
DESCRIPTION OF THE STUDY
Blood vessels are lined with a single layer of cells called the endothelium that influences
blood vessel diameter. Endothelial dysfunction is considered to be the earliest clinical
sign of increased cardiovascular disease risk and early detection of changes in this cell
layer may be beneficial for identifying individuals at higher risk for future cardiovascular
events. Brachial artery flow-mediated dilation (FMD) via ultrasound, venous occlusion
strain-gauge plethysmography (SGP), and peripheral artery tonometry (PAT) are
commonly employed non-invasive tools for the evaluation of vascular function. Your
participation in this study will last up to three weeks. Approximately 20 subjects will
participate in this study.
PROCEDURES
If you decide to be in this research study, you will be asked to sign this informed consent form
after you have had all of your questions answered. Whether or not you qualify for this study will
be based upon your physical characteristics and medical history. The criteria for inclusion in this
study are as follows: Sedentary males between 25-35 years of age with body mass index (BMI)
values <30 kg/m2. You will complete a medical history form prior to the beginning of the study.
You may not have any history of cardiovascular or metabolic disease, or be taking any
medication that might affect blood flow, blood vessel function, or the blood vessel responses to
exercise. You will also be excluded if you have a latex allergy since the assessment of vascular
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function with one of the techniques (PAT) requires contact with an inflatable finger cuff made
from latex. Testing sites include the Health and Human Performance Lab at 3600 W. Broad St.
and the General Clinic Research Center (GCRC) on the VCU Medical Center campus.
Participation in this study will require that you visit the testing sites on three occasions
approximately 1 week apart. During each visit, you will undergo baseline vascular function
assessment with one of the techniques, followed by a submaximal exercise bout, and concluding
with post-exercise vascular function assessment. Each visit will last approximately 2 hours.
The following measurements will be made during the study:
Anthropometric Measures. Your weight and height will be assessed with a scale and
stadiometer. These measurements will be utilized to calculate your BMI. These
measurements will be performed at 3600 W. Broad Street in the Health and Human
Performance Laboratory on your first visit. These measures will take approximately 10
minutes to complete.
Blood vessel. Blood flow through your vessels will be assessed using three different techniques:
Strain Gauge Plethysmography, Flow Mediated Dilation and Peripheral Artery Tonometry, each
which will last approximately 35 minutes.
• Strain Gauge Plethysmography: Blood pressure cuffs will be positioned around your
upper right arm and right wrist, and a mercury-in-rubber strain gauge will be placed
around your forearm. During each trial, the wrist cuff will be inflated to a pressure of 240
mmHg prior to each measurement to occlude hand circulation. Baseline FBF will be
determined by rapidly inflating the upper cuff to 40 mmHg for 4 seconds. Then, the
upper arm cuff will be inflated to 240 mmHg to induce forearm ischemia for a period of 5
minutes. After 5 minutes of occlusion, the cuff will be released and FBF, as described
above, will be determined during a 9 consecutive 12-second cycles.
• Flow Mediated Dilation: Brachial artery diameter at rest will be assessed with high
resolution ultrasound. Following the resting measures, a blood pressure cuff will be
positioned around your upper left arm and inflated to suprasystolic pressure to produce
ischemia for a period of 5 minutes. Following cuff release, your vessel diameter will be
reassessed
• Peripheral Artery Tonometry: A blood pressure cuff will be positioned around your upper
right arm and finger cuffs will be placed on your right and left index fingers. Baseline
blood flow changes will be measured for 5 minutes in both your right and left index
fingers prior to inflating the blood pressure cuff on your right upper arm to approximately
200 mmHg to induce a 5 minute period of forearm ischemia. Following cuff release, your
pulsatile blood flow changes will be reassessed.
Physical Activity Participation. Physical activity participation will be assessed at your first visit
using a physical activity recall questionnaire. This questionnaire will ask you questions about
the quantity and intensity of your physical activity over the previous 7 days. The questionnaire
will take approximately 5 minutes to complete.
Submaximal Exercise Bout. The submaximal exercise bout will begin with a three
minute warm up period on the treadmill at 3.0MPH, and 0% grade. You will then
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exercise on the treadmill at 75% of your age-predicted maximum heart rate for twenty
minutes. A brief cool down period of three minutes in length at 3.0MPH will follow the
exercise bout. You will then be taken to an examination room for post-exercise vascular
function measures.

RISKS AND DISCOMFORTS
Inflation of the cuff may cause discomfort, pain and tingling in your hands and fingers. As with
any exercise participation, there is also the slight chance of an abnormal blood pressure response,
fainting, and disorders of heart beat. In the event of a medical problem during testing, the
technicians will administer emergency first aid and then activate the appropriate emergency
medical system.
BENEFITS TO YOU AND OTHERS
You are not expected to receive any direct medical benefits from your participation in the
study. You will not receive any monetary compensation for your participation. However,
information from this study will help us better understand the similarities and differences
between techniques that assess vascular function.
COSTS
There are no costs for participating in this study other than the time commitment for the
three testing sessions.

ALTERNATIVE
This is not a treatment study. Your alternative is not to participate in this study.
CONFIDENTIALITY
Potentially identifiable information about you will consist of medical history forms,
measures of blood vessel function, body mass index, and physical activity participation.
Data are being collected for research purposes only. Your data will be identified by a
unique identifier, your name, and stored in a locked research area in the Health and
Human Performance Laboratory at 3600 W. Broad Street. All personal identifying
information will be kept in password protected files and these files will be deleted within
two years following the completion of the study. Access to all data will be limited to
study personnel.
You should know that research data about you may be reviewed or copied by Virginia
Commonwealth University. Personal information about you might be shared with or
copied by authorized officials of the Federal Food and Drug Administration, or the
Department of Health and Human Services (if applicable). Although results of this
research may be presented at meetings or in publications, identifiable personal
information pertaining to participants will not be disclosed.
COMPENSATION FOR INJURY
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Virginia Commonwealth University and the VCU Health System have no plan for
providing long-term care or compensation in the event that you suffer injury as a result of
your participation in this research study.
If you are injured or if you become ill as a result of your participation in this study,
contact a member of the research team immediately. A member of the study staff will
arrange for short-term emergency care if it is needed.
Fees for such treatment may be billed to you or to appropriate third party insurance.
Your health insurance company may or may not pay for treatment of injuries as a result
of your participation in this study.

VOLUNTARY PARTICIPATION AND WITHDRAWAL
Your participation in this study is voluntary. You may decide to not participate in this
study. Your decision not to take part will involve no penalty or loss of benefits to which
you are otherwise entitled. If you do participate, you may freely withdraw from the study
at any time. Your decision to withdraw will involve no penalty or loss of benefits to
which you are otherwise entitled.
Your participation in this study may be stopped at any time by the study doctor or the
sponsor without your consent. The reasons might include:
• the study staff thinks it necessary for your health or safety;
• you have not followed study instructions; or
• administrative reasons require your withdrawal.
QUESTIONS
In the future, you may have questions about your study participation. You may also have
questions about a possible side effect, reaction to study medication, or a possible
research-related injury. If you have any questions, complaints, or concerns about the
research, contact:
Ronald K. Evans, PhD
Department of Health and Human Performance
804-828-7798
rkevans@vcu.edu
If you have questions about your rights as a research subject, you may contact:
Office of Research
Virginia Commonwealth University
800 East Leigh Street, Suite 113
PO Box 980568
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Richmond, VA 23298
(804) 827-2157
You may also contact this number for general questions, concerns or complaints about
the research. Please call this number if you cannot reach the research team or wish to talk
to someone else.
Do not sign this consent form unless you have had a chance to ask questions and have
received satisfactory answers to all of your questions. Additional information about
participation in research studies can be found at
http://www.research.vcu.edu/irb/volunteers.htm.
CONSENT
I have been provided with an opportunity to read this consent form carefully. All of the
questions that I wish to raise concerning this study have been answered.
By signing this consent form, I have not waived any of the legal rights or benefits, to
which I otherwise would be entitled. My signature indicates that I freely consent to
participate in this research study. I will receive a copy of the consent form once I have
agreed to participate.

________________________________________________
Subject Name, printed

________________________________________________ ________________
Subject Signature
Date

________________________________________________
Name of Person Conducting Informed Consent
Discussion / Witness
(Printed)
________________________________________________ ________________
Signature of Person Conducting Informed Consent
Date
Discussion / Witness

________________________________________________ ________________
Investigator Signature (if different from above)
Date
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Department of Health and Human Performance
A Pre and Post Exercise Comparison of Three Assessment Tools Commonly
Employed to Evaluate Vascular Function
-

Please no do consume food or drinks after midnight the night before participating in the
study. Moderate water consumption is allowed.

-

No alcohol or tobacco for a minimum of 24 hours prior to your appointment.

-

Please refrain from exercise for a minimum of 48 hours prior to your appointment

-

Please wear or bring comfortable clothes and shoes for your treadmill test.

-

Please remove all fingernail polish on your index fingers prior to your visit.

-

When you arrive at the GCRC, you will be placed in a room and allowed to rest for a
minimum of 30 minutes prior to your testing session.
I.

Directions to VCU Medical Center:

Arriving by I-64 West - coming from Virginia Beach, Williamsburg, etc.
1.
2.
3.
4.
5.

Take Exit #190 for 5th Street and Downtown/Coliseum
Turn left at the 4th traffic light onto Marshall Street
Drive six blocks and turn left onto 11th Street
Drive one block and turn right onto Clay Street
Go one and one-half blocks to the Patient and Visitor Parking Decks E & S.

Arriving by I-64 East - coming from Charlottesville, I-81, etc.
1. Follow I-64 East which merges with I-95 South
2. Remain on I-95 south to Exit #74C for West Broad Street
3. Proceed West on Broad Street and follow directions given under "arrive by I-95
North"
Arriving by I-95 North - coming from Petersburg, North Carolina, etc.
1.
2.
3.
4.

Take Exit #74C for West Broad Street
Proceed West on Broad Street for three blocks to 11th Street, take right
Drive two blocks to Clay Street and turn right
Proceed one and one-half blocks to the Patient and Visitor Parking Decks E & S.

Arriving by I-95 South - coming from Washington, Fredericksburg, etc.
1. Take Exit #74C to West Broad Street
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2. Follow directions given under "arriving by I-95 North"
Arriving by U.S. Route 60 - coming from Lexington, etc.
1. Follow U.S. Route 60 which merges with 9th Street
2. Remain on 9th Street and go one block past Broad Street to Marshall Street and turn
right
3. Drive two blocks and turn left onto 11th Street
4. Drive one block and turn right onto Clay Street
5. Go one and one-half blocks to the Patient and Visitor Parking Decks E & S.
•

•

•

•

Valet parking is available for $5.00 at the entrances of the Gateway Building, ACC
and North Hospital. Parking for the Children’s Pavilion is available in the Pavilion’s
lower garage on 11th St. for $5.00.
The VCU Medical Center has a Patient and Visitor Parking Deck located at 12th and
Clay Streets. The Deck is open 24 hours daily. There is a charge for using this facility
during the week.
Reduced parking rates at the Visitor Parking Deck ($2.00 per visit) are available for
patients and visitors that obtain parking validation at the Information Desks located
on the first floor of ACC and Children’s' Pavilion; ground floor of Gateway and
Critical Care Hospital.
Lost parking tickets for the Patient and Visitor Parking Deck will be charged $10.00
upon exit unless a $2.00 validation is presented.

vp Valet Parking

P General Parking
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Arrive at the General Clinical Research Center (8th floor North Hospital) at least
15 minutes prior to your appointment time. North Hospital is accessible from the
Gateway building (Main entrance). Go up the escalators; walk straight, all the
way down the hallway (past the cafeteria), transition into North Hospital. Around
the corner you will see a set of elevators. Go to 8th floor (GCRC).

•

II.

Directions to 3600 West Broad Street (Health and Human Performance
Laboratory):

Arriving by I-64 West - coming from Virginia Beach, Williamsburg, etc.
1.
2.
3.
4.
5.
6.
7.

Take exit 70 towards Boulevard
Turn slight left to take the ramp toward VA-161
Turn left onto Hermitage Rd
Turn right onto Robin Hood Rd
Turn left onto Boulevard/VA-161 for 0.9 miles
Turn right onto W. Broad St/ US-250
3600 W. Broad St is on the right after 0.6 miles

Arriving by I-64 East - coming from Charlottesville, I-81, etc.
1.
2.
3.
4.
5.

Merge onto I-195 S via exit 79 toward US-60 W/Powhite Pkwy/ US 360W
Take the Hamilton St. exit toward US-33/US-250/BROAD ST
Take the ramp toward US-33/US-250/BROAD ST.
Turn left onto W. Broad St/US- 250
Arrive at 3600 W. Broad St on your left.

Arriving by I-95 North - coming from Petersburg, North Carolina, etc.
1.
2.
3.
4.
5.
6.

Merge onto I-195 N via exit 74 A toward VA-195-Toll/Downtown Expressway
Take exit toward US-33/US-250/Broad St
Turn slight right onto W. Clay St.
Turn right into Roseneath Rd.
Turn right onto W. Broad St/US-250/US-33
3600 W. Broad St/ US-250/US-33

Arriving by I-95 South - coming from Washington, Fredericksburg, etc
6. Merge onto I-195 S via exit 79 toward US-60 W/Powhite Pkwy/ US 360W
7. Take the Hamilton St. exit toward US-33/US-250/BROAD ST
8. Take the ramp toward US-33/US-250/BROAD ST.
9. Turn left onto W. Broad St/US- 250
10. Arrive at 3600 W. Broad St on your left.
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Arriving by U.S. Route 60 - coming from Lexington, etc
1.
2.
3.
4.
5.
6.

Merge onto I-64 E towards I-81/Staunton via exit 221 for 31 miles
Marge into I-195S via exit 186 towards Powhite Parkway
Take the Hamilton St. exit towards US-250/Broad St
Turn slight right onto N. Hamilton St.
Turn left onto W. Broad St.
Arrive at 3600 W. Broad St. on the left

•
•

There is a parking lot in the back of the building. Please park in the last row,
facing the highway.
If you have any questions regarding your appointment, please do not hesitate to
contact Lorena Salom at 240-476-7640. The General Clinical Research Center
can be contacted at 828-9101.
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1. SGP
2. Endo-PAT
3. Ultrasound
4. SGP
5. Endo-PAT
6. Ultrasound
7. SGP
8. Endo-PAT
9. Ultrasound
10.SGP
11.Endo-PAT
12.Ultrasound
13.SGP
14.Endo-PAT
15.Ultrasound
16.SGP
17.Endo-PAT
18.Ultrasound
19.SGP
20.Endo-PAT
21.Ultrasound
22.SGP
23.Endo-PAT
24.Ultrasound
25.SGP
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STRAIN GAUGE PLETHYSMOGRAPHY DETAILED METHODS

Subject should rest in the supine position on stretcher for about 30 minutes
prior to testing. Turn on arterial inflow system by switching power button to the
ON position. The switch is located on the top right corner of the cart, behind the
computer screen. Then, press the power button on the central processing unit to
turn on computer. Using the mouse, double click on the green AI6 icon on
desktop to open AI6 program.
Ask subject to raise their dominant arm, and to bend their elbow. Find
olecranon process on the subject’s dominant arm and measure approximately
10cm distal to the olecranon process to find widest part of the forearm and mark
arm with a pen. Measure the circumference around the forearm of the dominant
arm, and record. Select a strain gauge that is 2 to 3cms smaller than forearm
circumference. Wrap large blood pressure cuff around the upper dominant arm
tightly. A small blood pressure cuff should be tightly wrapped around dominant
arm’s wrist. This cuff will be inflated to suprasystolic pressures to completely
occlude hand circulation during test; therefore isolating forearm circulation. Make
sure both blood pressure cuffs are connected to the inflators on the cart.
Carefully loop mercury-filled strain gauge around the widest part of the forearm,
previously marked. The strain gauge strands should be even around the forearm,
with both bands parallel to one another. Secure strain gauge in place by hooking
the end of the mercury-filled band over the plastic head of the strain gauge. Place
a small piece of adhesive tape over the plastic head to secure strain gauge to arm.
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Plug in strain gauge to jack labeled “Strain Gauge 1” on the AI6 cart. The
dominant arm should be raised approximately 10° above heart level by supporting
the upper arm and hand with foam blocks. Avoid placing foam blocks on the
forearm, as the strain gauge should not be touched. Ask the subject to be still and
refrain from speaking, as this instrument is very sensitive to motion. Apply three
electrodes to subject’s chest; two just below the clavicle on both sides. The third
electrode should be placed on the left side, on the anterior axillary line, slightly
above the navel. The skin should be prepped by briskly rubbing it with an alcohol
pad. Shave off excess hair if necessary. Once all electrodes are applied, connect
white Electrocardiogram (ECG) lead to the right upper electrode, the black lead to
the upper left electrode, and the red lead to the lower left electrode.
Running the test:
Phase 1
Click on “Patient” on the top right corner of the screen, then on “Enter
Demographics”. Fill out the required fields, Patient ID and Last Name. Click
“Close”. This will store information on database. Check Pressure Settings box on
the bottom right corner of the screen. Desired Wrist Pressure should be set at 250
mm Hg for total occlusion. Desired Venous Pressure should be set at 40mmHg.
Click “SGP Balance” to manually calibrate and zero the plethysmographs. The
AI6 will recalibrate the plethysmograph prior to each reading during arterial flow
measurements. Press the “Start” button to begin test. Nine measurements will be
recorded to determine the average rate of volume change during venous occlusion
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(ml/100 ml of forearm tissue volume/min). Pause test following the end of the
ninth measurement. This demarcates the end of Phase 1.
Phase 2:
1. Check “Ischemic Stress” box, located in the Pressure Settings box on the bottom
right corner of the screen. Stress Pressure should be set to 240mm Hg, and the stress
period should be set at 300 seconds. Click on the “Resume” button at the bottom
right corner of the screen to start the ischemic stress period. The upper arm cuff will
inflate to 240 mm Hg to induce forearm ischemia for a period of five minutes (300s).
Following the five minute long Ischemic stress period, the cuff will be quickly
deflated and forearm blood flow will be determined in the same manner as Phase 1.
Allow for 9 post-ischemia test stages then click to End Test.
Repeat procedure following acute exercise bout.
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FLOW MEDIATED DILATION VIA ULTRASOUND DETAILED METHODS

The subject should be in the supine position, resting for thirty minutes
prior to the start of the research trial. Position the subject so that the arm is in a
comfortable position for imaging the brachial artery. Place large blood pressure
around the forearm of test arm, and acquire a resting blood pressure measurement
in the control arm. Apply three electrodes to subject’s chest; two just below the
clavicle on both sides. The third electrode should be placed on the left side, on the
anterior axillary line, slightly above the navel. The skin should be prepped by
briskly rubbing it with an alcohol pad. Shave off excess hair if necessary. Once all
electrodes are applied, connect white Electrocardiogram (ECG) lead to the right
upper electrode, the black lead to the upper left electrode, and the red lead to the
lower left electrode.
The brachial artery should be located on the test arm by a trained
ultrasonographer. Once the vessel has been located, data collection can begin.
Press the record button for 10 to 12 heart beats, then press the “Pulse” button and
correct the angle so that it is parallel to the vessel. Adjust the baseline to the
appropriate values, then press HighQ. Continue to record for 10 to 12 beats for
baseline flow. Press record again to pause recording. Inflate blood pressure cuff to
240mm Hg and start stop watch. At 4 minutes 30 seconds, press the record button.
At 4 minutes 45 seconds, press pulse, correct the angle and press update. When
the stopwatch marks 5 minutes, release the pressure from the blood pressure cuff,
and press reset on the VCR timer. Continue to capture flow measurements until
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flow start to noticeably drop, which will occurs in 20 to 25 seconds. Press the
update button and pulse to get back to the vessel diameter screen. Continue to
record the best image possible for 2 minutes post occlusion. Repeat procedure
following the acute exercise bout.

97

APPENDIX G
ENDO PAT DETAILED METHODS

98

ENDO PAT DETAILED METHODS

Turn on Endo-PAT unit at least twenty minutes prior to test to allow machine to
warm up. Turn on laptop and connect it to the Endo-PAT unit. Attach the fingertip like
bio-sensors to apparatus. The bio-sensor probes are lined with latex; therefore subjects
with latex allergies should be excluded from participating in the research study.
Click on Endo-PAT icon on the desk top. Once program has opened, a green EndoPAT™
icon should light up at the right bottom corner of the screen, indicating communication
between the computer and the Endo-PAT unit. Click on “Patient ID” and fill out patient
information.
Prior to the start of each research trial, subjects should rest in the supine position for
thirty minutes. Resting blood pressure should be taken on the control arm approximately
half way through the resting period. Check the subject’s finger nails, they should be short
and clean. Nails that protrude more than five mm from the fingertip should be trimmed. If
there is nail polish on the nails, remove it with acetone. Remove all jewelry from the
subject. Place finger probes on the subject’s index fingers, and blue foam anchor around
the middle finger. The foam anchor should be pushed down towards the root of the
finger. Place blood cuff around the upper arm of the control arm. Both arms should be
placed at the sides of the subject’s body and elevated to heart level by resting the arms on
the specialized blue cushions. The index fingers should be placed inside the finger holes
at the top of the specialized cushions to avoid the finger probe to come in contact and
provide support. Inflate finger cuff by pressing the inflate button on the Endo-PAT unit.
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Press the yellow Standby button for one minute. Then, press the green “Go” icon to start
recording data. Collect baseline data for a minimum of three minutes ( says that should be
for at least 5 to10 minutes?). Quickly inflate blood pressure cuff to 240 mmHg to occlude
blood floor to the arm for a total of five minutes. Rapidly deflate blood pressure cuff and
continue to collect data for another three minutes. Click the “Stop” button to end test.
Patient set up:
Prior to the start of each research trial, subjects should rest in the supine position for
thirty minutes. Resting blood pressure should be taken on the control arm approximately
half way through the resting period. Check the subject’s finger nails, they should be short
and clean. Nails that protrude more than five mm from the fingertip should be trimmed. If
there is nail polish on the nails, remove it with acetone. Remove all jewelry from the
subject. Place finger probes on the subject’s index fingers, and blue foam anchor around
the middle finger. The foam anchor should be pushed down towards the root of the
finger. Place blood cuff around the upper arm of the control arm. Both arms should be
placed at the sides of the subject’s body and elevated to heart level by resting the arms on
the specialized blue cushions. The index fingers should be placed inside the finger holes
at the top of the specialized cushions to avoid the finger probe to come in contact and
provide support. Inflate finger cuff by pressing the inflate button on the Endo-PAT unit.
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TREADMILL OPERATION

1) Turn on system. Button is on the right hand side of the system
2) Press Ctrl+ Alt+ Del
3) Password is “User”
4) Once the program has loaded, click on “next page” until reaching “TEST-DEMO”
in the Select patient (local database) window, then press “Select”.
5) A window will come up that states “No Connection to BP”, Click OK
6) Press the blue Exercise button on the left side of the panel right above the
keyboard. Then, click blue “Start Treadmill” button on the right side of the panel.
a. Increase speed for warm up to 3.0 MPH for 3 minutes.
b. Increase speed to reach 75% of the subject’s age predicted max HR,
exercise bout lasts for 20 minutes.
c. Decrease speed for cool down to 3.0 MPH for 3 minutes.
7) Press the red “Stop treadmill” button on the right hand side.
8) Press the blue “Test end” button on the left hand side of the panel.
9) Click Yes on the “Test end” window.
10) Click OK on the next window that appears.
11) Click OK on the BP window if it appears.
12) Click on the “Initial Screen” button on the right upper corner of the screen.
13) Click OK on the window that says “The patient ECG waveforms will no longer to
displayed”
14) Press “Turn off Program”. Then click Yes on the “Do you want to terminate the
program and shut down the device” window. This turns off the system.
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